Upregulation	O
of	O
interleukin	B-protein
6	I-protein
and	O
granulocyte	B-protein
colony-stimulating	I-protein
factor	I-protein
receptors	I-protein
by	O
transcription	B-protein
factor	I-protein
CCAAT	B-protein
enhancer	I-protein
binding	I-protein
protein	I-protein
alpha	I-protein
(	O
C/EBP	B-protein
alpha	I-protein
)	O
is	O
critical	O
for	O
granulopoiesis	O
.	O

Cytokines	O
stimulate	O
granulopoiesis	O
through	O
signaling	O
via	O
receptors	O
whose	O
expression	O
is	O
controlled	O
by	O
lineage-specific	O
transcription	B-protein
factors	I-protein
.	O

Previously	O
,	O
we	O
demonstrated	O
that	O
granulocyte	B-RNA
colony-stimulating	I-RNA
factor	I-RNA
(	I-RNA
G-CSF	I-RNA
)	I-RNA
receptor	I-RNA
mRNA	I-RNA
was	O
undetectable	O
and	O
granulocyte	O
maturation	O
blocked	O
in	O
CCAAT	B-protein
enhancer	I-protein
binding	I-protein
protein	I-protein
alpha	I-protein
(	O
C/EBPalpha	B-protein
)	O
-deficient	O
mice	O
.	O

This	O
phenotype	O
is	O
distinct	O
from	O
that	O
of	O
G-CSF	O
receptor-/-	O
mice	O
,	O
suggesting	O
that	O
other	O
genes	O
are	O
likely	O
to	O
be	O
adversely	O
affected	O
by	O
loss	O
of	O
C/EBPalpha	B-protein
.	O

Here	O
we	O
demonstrate	O
loss	O
of	O
interleukin	B-protein
6	I-protein
(	I-protein
IL-6	I-protein
)	I-protein
receptor	I-protein
and	O
IL-6-responsive	B-protein
colony-forming	I-protein
units	I-protein
(	O
CFU-IL6	B-protein
)	O
in	O
C/EBPalpha	B-protein
-/-	O
mice	O
.	O

The	O
observed	O
failure	O
of	O
granulopoiesis	O
could	O
be	O
rescued	O
by	O
the	O
addition	O
of	O
soluble	O
IL-6	B-protein
receptor	I-protein
and	O
IL-6	B-protein
or	O
by	O
retroviral	O
transduction	O
of	O
G-CSF	B-protein
receptors	I-protein
,	O
demonstrating	O
that	O
loss	O
of	O
both	O
of	O
these	O
receptors	O
contributes	O
to	O
the	O
absolute	O
block	O
in	O
granulocyte	O
maturation	O
observed	O
in	O
C/EBPalpha-deficient	B-cell_type
hematopoietic	I-cell_type
cells	I-cell_type
.	O

The	O
results	O
of	O
these	O
and	O
other	O
studies	O
suggest	O
that	O
additional	O
C/EBPalpha	B-DNA
target	I-DNA
genes	I-DNA
,	O
possibly	O
other	O
cytokine	O
receptors	O
,	O
are	O
also	O
important	O
for	O
the	O
block	O
in	O
granulocyte	O
differentiation	O
observed	O
in	O
vivo	O
in	O
C/EBPalpha	B-protein
-deficient	O
mice	O
.	O

Upregulation	NULL
of	NULL
Interleukin	NULL
6	NULL
and	NULL
Granulocyte	NULL
Colony-	NULL
Stimulating	NULL
Factor	NULL
Receptors	NULL
by	NULL
Transcription	NULL
Factor	NULL
CCAAT	NULL
Enhancer	NULL
Binding	NULL
Protein	NULL
«	NULL
(	NULL
C/	NULL
EBPa	NULL
)	NULL
Is	NULL
Critical	NULL
for	NULL
Granulopoiesis	NULL
By	NULL
Pu	NULL
Zhang	NULL
,	NULL
*	NULL
Atsushi	NULL
Iwama	NULL
,	NULL
*	NULL
Milton	NULL
W.	NULL
Datta	NULL
,	NULL
*	NULL
Gretchen	NULL
J.	NULL
Darlington	NULL
,	NULL
*	NULL
Daniel	NULL
C.	NULL
Link	NULL
,	NULL
$	NULL
and	NULL
Daniel	NULL
G.	NULL
Tenen*	NULL
From	NULL
the	NULL
*	NULL
Division	NULL
of	NULL
Hematology/	NULL
O	NULL
nology	NULL
,	NULL
Department	NULL
of	NULL
Mediane	NULL
,	NULL
Beth	NULL
Isrel	NULL
Deawness	NULL
Medial	NULL
Center	NULL
and	NULL
Harvard	NULL
Media	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02215	NULL
;	NULL
the	NULL
*Department	NULL
of	NULL
Pathology	NULL
and	NULL
Molecular	NULL
and	NULL
Human	NULL
Genetics	NULL
Baylor	NULL
College	NULL
of	NULL
Mediane	NULL
,	NULL
Houston	NULL
,	NULL
Texas	NULL
77030	NULL
;	NULL
and	NULL
the	NULL
$	NULL
Division	NULL
of	NULL
Bone	NULL
Marrow	NULL
Trimsplantation	NULL
and	NULL
Stem	NULL
Cell	NULL
Biology	NULL
,	NULL
Department	NULL
of	NULL
Mediane	NULL
,	NULL
Washington	NULL
University	NULL
Medical	NULL
School	NULL
,	NULL
St.	NULL
Louis	NULL
Missount	NULL
63110-1093	NULL
Sum	NULL
m	NULL
ary	NULL
Cytokines	NULL
stimulate	NULL
granulopoiesis	NULL
through	NULL
signaling	NULL
via	NULL
receptors	NULL
whose	NULL
expression	NULL
is	NULL
controlled	NULL
by	NULL
lineage-specific	NULL
transcription	NULL
factors	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
granulocyte	NULL
colony-	NULL
stimulating	NULL
factor	NULL
(	NULL
G-CSF	NULL
)	NULL
receptor	NULL
mR	NULL
N	NULL
A	NULL
was	NULL
undetectable	NULL
and	NULL
granulocyte	NULL
maturation	NULL
blocked	NULL
in	NULL
CCAAT	NULL
enhancer	NULL
binding	NULL
protein	NULL
«	NULL
(	NULL
C/	NULL
EBPa	NULL
)	NULL
-deficient	NULL
mice	NULL
.	NULL

This	NULL
phenotype	NULL
is	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
G-CSF	NULL
receptor~'~-	NULL
mice	NULL
,	NULL
suggesting	NULL
that	NULL
other	NULL
genes	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
adversely	NULL
affected	NULL
by	NULL
loss	NULL
of	NULL
C/	NULL
EBPa	NULL
.	NULL

Here	NULL
we	NULL
demonstrate	NULL
loss	NULL
of	NULL
interleukin	NULL
6	NULL
(	NULL
IL-6	NULL
)	NULL
receptor	NULL
and	NULL
IL-6-responsive	NULL
colony-forming	NULL
units	NULL
(	NULL
CFU-IL6	NULL
)	NULL
in	NULL
C/EBPa~'~	NULL
mice	NULL
.	NULL

The	NULL
observed	NULL
failure	NULL
of	NULL
granulopoiesis	NULL
could	NULL
be	NULL
rescued	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
and	NULL
IL-6	NULL
or	NULL
by	NULL
retroviral	NULL
transduction	NULL
of	NULL
G-CSF	NULL
receptors	NULL
,	NULL
demonstrating	NULL
that	NULL
loss	NULL
of	NULL
both	NULL
of	NULL
these	NULL
receptors	NULL
contributes	NULL
to	NULL
the	NULL
absolute	NULL
block	NULL
in	NULL
granulocyte	NULL
maturation	NULL
observed	NULL
in	NULL
C/	NULL
EBPa-deficient	NULL
hematopoietic	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
of	NULL
these	NULL
and	NULL
other	NULL
studies	NULL
suggest	NULL
that	NULL
additional	NULL
C/	NULL
EBP	NULL
«	NULL
target	NULL
genes	NULL
,	NULL
possibly	NULL
other	NULL
cytokine	NULL
receptors	NULL
,	NULL
are	NULL
also	NULL
important	NULL
for	NULL
the	NULL
block	NULL
in	NULL
granulocyte	NULL
differentiation	NULL
observed	NULL
in	NULL
vivo	NULL
in	NULL
C/	NULL
EBPa	NULL
«	NULL
-deficient	NULL
mice	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
hematopoiesis	NULL
«	NULL
myelopoiesis	NULL
Multipotential	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
differentiate	NULL
into	NULL
all	NULL
of	NULL
the	NULL
different	NULL
lineages	NULL
of	NULL
blood	NULL
cells	NULL
The	NULL
processes	NULL
of	NULL
distinct	NULL
lineage	NULL
differentiation	NULL
is	NULL
regulated	NULL
by	NULL
distinct	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
GAT	NULL
A-1	NULL
for	NULL
erythroid	NULL
cells	NULL
,	NULL
PU.1	NULL
for	NULL
myeloid	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
CCAAT	NULL
enhancer	NULL
binding	NULL
protein	NULL
«	NULL
(	NULL
C/EBPa	NULL
)	NULL
'	NULL
for	NULL
granulocytes	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
for	NULL
how	NULL
these	NULL
factors	NULL
regulate	NULL
hematopoietic	NULL
stem	NULL
cell	NULL
differentiation	NULL
is	NULL
still	NULL
not	NULL
clear	NULL
.	NULL

Interestingly	NULL
,	NULL
all	NULL
of	NULL
these	NULL
factors	NULL
can	NULL
positively	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
lineage-specific	NULL
growth	NULL
factor	NULL
receptors	NULL
.	NULL

For	NULL
example	NULL
,	NULL
GATA-1	NULL
activates	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
promoter	NULL
(	NULL
3	NULL
)	NULL
,	NULL
PU.1	NULL
is	NULL
critical	NULL
for	NULL
M-CSF	NULL
receptor	NULL
promoter	NULL
activity	NULL
'	NULL
A	NULL
bbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
C/EBP	NULL
,	NULL
CCAAT	NULL
enhancer	NULL
binding	NULL
pro-tein	NULL
;	NULL
CFU-GM	NULL
,	NULL
GM-CSF-responsive	NULL
CFU	NULL
;	NULL
CFU-IL3	NULL
and	NULL
-IL6	NULL
,	NULL
IL-3	NULL
and	NULL
IL-6-responsive	NULL
CFU	NULL
,	NULL
respectively	NULL
;	NULL
RT	NULL
,	NULL
reverse	NULL
transcription	NULL
;	NULL
SCF	NULL
,	NULL
stem	NULL
cell	NULL
factor	NULL
.	NULL

1173	NULL
CCAAT	NULL
enhancer	NULL
binding	NULL
protein	NULL
*	NULL
knockout	NULL
mice	NULL
*	NULL
colony-forming	NULL
unit	NULL
®	NULL
(	NULL
4	NULL
)	NULL
,	NULL
and	NULL
C/	NULL
EBPa	NULL
«	NULL
is	NULL
an	NULL
important	NULL
regulator	NULL
of	NULL
G-CSF	NULL
receptor	NULL
promoter	NULL
function	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
one	NULL
possible	NULL
mechanism	NULL
of	NULL
transcription	NULL
factor	NULL
regulation	NULL
of	NULL
lineage	NULL
differentiation	NULL
is	NULL
through	NULL
activation	NULL
of	NULL
cell	NULL
type-specific	NULL
cytokine	NULL
receptors	NULL
.	NULL

C/	NULL
EBPa	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
C/	NULL
EBP	NULL
transcription	NULL
factor	NULL
family	NULL
(	NULL
6	NULL
)	NULL
.	NULL

O	NULL
ther	NULL
members	NULL
of	NULL
this	NULL
family	NULL
include	NULL
C/	NULL
EBP	NULL
,	NULL
or	NULL
NF-IL6	NULL
,	NULL
which	NULL
is	NULL
critical	NULL
for	NULL
macrophage	NULL
activation	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
,	NULL
and	NULL
C/	NULL
EBPe	NULL
,	NULL
which	NULL
regulates	NULL
granulocyte	NULL
maturation	NULL
at	NULL
a	NULL
very	NULL
terminal	NULL
stage	NULL
(	NULL
9	NULL
)	NULL
.	NULL

C/	NULL
EBPa	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
a	NULL
number	NULL
of	NULL
hepatocyte	NULL
and	NULL
adipocyte	NULL
genes	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Targeted	NULL
deletion	NULL
of	NULL
the	NULL
C/EBPa	NULL
gene	NULL
in	NULL
mice	NULL
disrupts	NULL
normal	NULL
glucose	NULL
metabolism	NULL
,	NULL
and	NULL
homozygous	NULL
newborn	NULL
animals	NULL
die	NULL
from	NULL
hypoglycemia	NULL
within	NULL
8	NULL
h	NULL
of	NULL
birth	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

In	NULL
the	NULL
hematopoietic	NULL
system	NULL
,	NULL
C/	NULL
EBPa	NULL
is	NULL
expressed	NULL
specifically	NULL
in	NULL
both	NULL
human	NULL
and	NULL
murine	NULL
myeloid	NULL
cells	NULL
(	NULL
14	NULL
)	NULL
.	NULL

It	NULL
up-regulates	NULL
several	NULL
myeloid	NULL
gene	NULL
promoters	NULL
,	NULL
such	NULL
as	NULL
G-CSF	NULL
receptor	NULL
(	NULL
5	NULL
)	NULL
,	NULL
myeloperoxidase	NULL
(	NULL
15	NULL
,	NULL
15a	NULL
)	NULL
,	NULL
and	NULL
neutrophil	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

©	NULL
The	NULL
R	NULL
ockefeller	NULL
University	NULL
Press	NULL
»	NULL
0022-1007/98/09/	NULL
1173/	NULL
12	NULL
$	NULL
2.00	NULL
Volume	NULL
188	NULL
,	NULL
Number	NULL
6	NULL
,	NULL
September	NULL
21	NULL
,	NULL
1998	NULL
1173-1184	NULL
http	NULL
:	NULL
//	NULL
www.jem.org	NULL
elastase	NULL
(	NULL
15a	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
C/	NULL
EBPa	NULL
expression	NULL
is	NULL
selectively	NULL
maintained	NULL
during	NULL
granulocytic	NULL
differentiation	NULL
,	NULL
but	NULL
is	NULL
markedly	NULL
downregulated	NULL
with	NULL
monocytic	NULL
differentiation	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
reported	NULL
that	NULL
granulocyte	NULL
maturation	NULL
was	NULL
completely	NULL
blocked	NULL
in	NULL
C/	NULL
EBPa-deficient	NULL
mice	NULL
,	NULL
but	NULL
T	NULL
cell	NULL
,	NULL
B	NULL
cell	NULL
,	NULL
and	NULL
macrophage	NULL
subsets	NULL
were	NULL
normal	NULL
.	NULL

Expression	NULL
of	NULL
G-CSF	NULL
receptor	NULL
mR	NULL
N	NULL
A	NULL
was	NULL
profoundly	NULL
and	NULL
selectively	NULL
re-duced	NULL
,	NULL
whereas	NULL
levels	NULL
of	NULL
M-CSF	NULL
receptor	NULL
,	NULL
GM-CSF	NULL
receptor	NULL
«	NULL
,	NULL
and	NULL
IL-3	NULL
receptor	NULL
«	NULL
mRNA	NULL
were	NULL
all	NULL
comparable	NULL
to	NULL
wild-type	NULL
(	NULL
18	NULL
)	NULL
.	NULL

No	NULL
defects	NULL
were	NULL
observed	NULL
in	NULL
C/EBPa*'~	NULL
mice	NULL
.	NULL

However	NULL
,	NULL
mice	NULL
with	NULL
a	NULL
targeted	NULL
disruption	NULL
of	NULL
the	NULL
G-CSF	NULL
receptor	NULL
only	NULL
have	NULL
a	NULL
quantitative	NULL
defect	NULL
in	NULL
granu-lopoiesis	NULL
;	NULL
mature	NULL
granulocyte	NULL
are	NULL
still	NULL
detected	NULL
at	NULL
a	NULL
level	NULL
12	NULL
%	NULL
of	NULL
wild-type	NULL
(	NULL
19	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
G-CSF	NULL
receptor	NULL
,	NULL
other	NULL
genes	NULL
were	NULL
likely	NULL
to	NULL
be	NULL
affected	NULL
by	NULL
loss	NULL
of	NULL
the	NULL
C/	NULL
EBPa	NULL
gene	NULL
.	NULL

Multiple	NULL
cytokines	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
granulopoiesis	NULL
,	NULL
including	NULL
G-CSF	NULL
,	NULL
GM-CSF	NULL
,	NULL
IL-3	NULL
,	NULL
and	NULL
IL-6	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Mice	NULL
that	NULL
have	NULL
been	NULL
treated	NULL
with	NULL
IL-6	NULL
have	NULL
an	NULL
increased	NULL
number	NULL
of	NULL
peripheral	NULL
neutrophils	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Double	NULL
transgenic	NULL
mice	NULL
which	NULL
coexpress	NULL
human	NULL
IL-6	NULL
and	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
demonstrate	NULL
dramatic	NULL
increases	NULL
of	NULL
white	NULL
blood	NULL
cells	NULL
consisting	NULL
mainly	NULL
of	NULL
neutrophilic	NULL
granulocytes	NULL
compared	NULL
with	NULL
wild-type	NULL
,	NULL
single	NULL
transgenic	NULL
mice	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Coadmin-istration	NULL
of	NULL
recombinant	NULL
human	NULL
IL-6	NULL
and	NULL
G-CSF	NULL
to	NULL
irradia-tion-induced	NULL
myelosuppressed	NULL
mice	NULL
caused	NULL
a	NULL
synergistic	NULL
increase	NULL
in	NULL
the	NULL
GM-CSF-responsive	NULL
CFU	NULL
(	NULL
CFU-GM	NULL
)	NULL
in	NULL
peripheral	NULL
blood	NULL
and	NULL
bone	NULL
marrow	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Loss	NULL
of	NULL
IL-6	NULL
in	NULL
G-CSF	NULL
receptor-deficient	NULL
mice	NULL
leads	NULL
to	NULL
a	NULL
significant	NULL
further	NULL
reduction	NULL
in	NULL
the	NULL
number	NULL
of	NULL
mature	NULL
neutrophils	NULL
in	NULL
peripheral	NULL
blood	NULL
and	NULL
bone	NULL
marrow	NULL
(	NULL
25	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
IL-6	NULL
also	NULL
regulates	NULL
granulopoiesis	NULL
,	NULL
and	NULL
that	NULL
IL-6	NULL
and	NULL
G-CSF	NULL
may	NULL
have	NULL
a	NULL
synergistic	NULL
effect	NULL
on	NULL
myelopoiesis	NULL
.	NULL

The	NULL
biological	NULL
effects	NULL
of	NULL
IL-6	NULL
are	NULL
known	NULL
to	NULL
be	NULL
mediated	NULL
through	NULL
their	NULL
unique	NULL
cell	NULL
surface	NULL
receptors	NULL
(	NULL
21	NULL
)	NULL
.	NULL

IL-6	NULL
receptors	NULL
are	NULL
expressed	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
plasma-cytoma	NULL
cells	NULL
,	NULL
macrophages	NULL
,	NULL
T	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
pre-B	NULL
cells	NULL
(	NULL
26	NULL
)	NULL
.	NULL

During	NULL
embryogenesis	NULL
,	NULL
it	NULL
is	NULL
expressed	NULL
constitutively	NULL
at	NULL
readily	NULL
detectable	NULL
levels	NULL
that	NULL
do	NULL
not	NULL
change	NULL
significantly	NULL
during	NULL
in	NULL
vitro	NULL
embryoid	NULL
body	NULL
development	NULL
and	NULL
blastocyst	NULL
development	NULL
(	NULL
27	NULL
)	NULL
.	NULL

In	NULL
the	NULL
hematopoietic	NULL
system	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
IL-6	NULL
receptor	NULL
rapidly	NULL
decreases	NULL
to	NULL
undetectable	NULL
levels	NULL
during	NULL
erythroid	NULL
differentiation	NULL
,	NULL
and	NULL
slowly	NULL
decreases	NULL
during	NULL
granulocyte	NULL
differentiation	NULL
(	NULL
28	NULL
)	NULL
.	NULL

IL-6	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
IL-6	NULL
receptor	NULL
with	NULL
low	NULL
affinity	NULL
(	NULL
29	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
gp130	NULL
,	NULL
a	NULL
signal	NULL
transducer	NULL
not	NULL
only	NULL
for	NULL
IL-6	NULL
but	NULL
also	NULL
for	NULL
leukocyte	NULL
inhibition	NULL
factor	NULL
(	NULL
LIF	NULL
)	NULL
,	NULL
Oncostatin	NULL
M	NULL
,	NULL
IL-11	NULL
,	NULL
and	NULL
ciliary	NULL
neurotrophic	NULL
factor	NULL
,	NULL
together	NULL
with	NULL
IL-6	NULL
will	NULL
result	NULL
in	NULL
high-affinity	NULL
IL-6	NULL
binding	NULL
and	NULL
subsequent	NULL
signal	NULL
transduction	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
IL-6	NULL
receptor	NULL
is	NULL
apparently	NULL
not	NULL
required	NULL
for	NULL
high-affinity	NULL
IL-6	NULL
binding	NULL
and	NULL
signal	NULL
transduction	NULL
,	NULL
since	NULL
the	NULL
soluble	NULL
form	NULL
of	NULL
the	NULL
IL-6	NULL
receptor	NULL
,	NULL
when	NULL
complexed	NULL
to	NULL
IL-6	NULL
,	NULL
can	NULL
also	NULL
trigger	NULL
high-affinity	NULL
IL-6	NULL
binding	NULL
and	NULL
signaling	NULL
on	NULL
target	NULL
cells	NULL
lacking	NULL
IL-6	NULL
receptor	NULL
but	NULL
expressing	NULL
gp	NULL
130	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
G-CSF	NULL
receptor	NULL
and	NULL
gp130	NULL
share	NULL
significant	NULL
similarity	NULL
within	NULL
their	NULL
cytoplasmic	NULL
domains	NULL
(	NULL
21	NULL
,	NULL
30	NULL
)	NULL
.	NULL

1174	NULL
Here	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
IL-6	NULL
receptor	NULL
is	NULL
markedly	NULL
downregulated	NULL
in	NULL
C/EBPa~'-	NULL
mice	NULL
,	NULL
whereas	NULL
the	NULL
expression	NULL
level	NULL
of	NULL
gp130	NULL
in	NULL
C/EBPa~'~	NULL
mice	NULL
is	NULL
comparable	NULL
with	NULL
the	NULL
level	NULL
in	NULL
wild-type	NULL
mice	NULL
.	NULL

C/EBPa	NULL
«	NULL
~'~	NULL
progenitors	NULL
do	NULL
not	NULL
respond	NULL
to	NULL
IL-6	NULL
alone	NULL
in	NULL
vitro	NULL
,	NULL
but	NULL
a	NULL
small	NULL
number	NULL
of	NULL
precursors	NULL
can	NULL
differentiate	NULL
to	NULL
metamyelocytic	NULL
granulocytes	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
to	NULL
the	NULL
culture	NULL
.	NULL

Addition	NULL
of	NULL
G-CSF	NULL
together	NULL
with	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
and	NULL
IL-6	NULL
induces	NULL
formation	NULL
of	NULL
mature	NULL
segmented	NULL
granulocytes	NULL
C/EBP	NULL
«	NULL
~'~	NULL
fetal	NULL
liver	NULL
hematopoietic	NULL
cells	NULL
also	NULL
can	NULL
be	NULL
rescued	NULL
in	NULL
vitro	NULL
by	NULL
transduction	NULL
of	NULL
G-CSF	NULL
receptors	NULL
into	NULL
the	NULL
cells	NULL
by	NULL
using	NULL
retroviral	NULL
infection	NULL
.	NULL

These	NULL
studies	NULL
demonstrate	NULL
that	NULL
the	NULL
IL-6	NULL
receptor	NULL
is	NULL
a	NULL
second	NULL
major	NULL
target	NULL
gene	NULL
for	NULL
C/EBPa	NULL
.	NULL

Restoration	NULL
of	NULL
expression	NULL
of	NULL
either	NULL
receptor	NULL
can	NULL
restore	NULL
granulopoiesis	NULL
in	NULL
vitro	NULL
,	NULL
demonstrating	NULL
that	NULL
they	NULL
are	NULL
important	NULL
functional	NULL
targets	NULL
for	NULL
C/	NULL
EBPa	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Hematologial	NULL
Analysis	NULL
.	NULL

Human	NULL
recombinant	NULL
IL-6	NULL
(	NULL
500	NULL
ng/	NULL
ml	NULL
)	NULL
,	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
(	NULL
100	NULL
ng/	NULL
m1	NULL
)	NULL
,	NULL
and	NULL
G-CSF	NULL
(	NULL
1,000	NULL
U/	NULL
ml	NULL
)	NULL
,	NULL
which	NULL
are	NULL
all	NULL
active	NULL
on	NULL
murine	NULL
cells	NULL
,	NULL
and	NULL
murine	NULL
recombinant	NULL
IL-3	NULL
(	NULL
300	NULL
U/	NULL
ml	NULL
)	NULL
and	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/	NULL
ml	NULL
)	NULL
were	NULL
used	NULL
in	NULL
the	NULL
CFU	NULL
assays	NULL
.	NULL

Methylcellulose	NULL
culture	NULL
of	NULL
single	NULL
cell	NULL
suspensions	NULL
of	NULL
fetal	NULL
liver	NULL
cells	NULL
was	NULL
performed	NULL
in	NULL
IMDM	NULL
medium	NULL
containing	NULL
0.8	NULL
%	NULL
methylcellulose	NULL
and	NULL
either	NULL
30	NULL
%	NULL
heat-	NULL
inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
for	NULL
IL-6	NULL
and	NULL
G-CSF	NULL
CFU	NULL
assays	NULL
,	NULL
or	NULL
20	NULL
%	NULL
heat-inactivated	NULL
serum	NULL
for	NULL
the	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
CFU	NULL
assays	NULL
.	NULL

10	NULL
%	NULL
Chinese	NULL
hamster	NULL
ovary	NULL
cell-conditioned	NULL
medium	NULL
from	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
a	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
SCF	NULL
)	NULL
expression	NULL
vector	NULL
was	NULL
used	NULL
as	NULL
a	NULL
source	NULL
of	NULL
SCF	NULL
,	NULL
and	NULL
10	NULL
%	NULL
WEHI-3-conditioned	NULL
medium	NULL
was	NULL
used	NULL
as	NULL
a	NULL
source	NULL
of	NULL
IL-3	NULL
for	NULL
liquid	NULL
cultures	NULL
.	NULL

Colonies	NULL
were	NULL
counted	NULL
at	NULL
days	NULL
7-9	NULL
.	NULL

Two	NULL
to	NULL
four	NULL
colonies	NULL
were	NULL
pooled	NULL
and	NULL
cytocentrifuged	NULL
onto	NULL
glass	NULL
slides	NULL
daily	NULL
after	NULL
day	NULL
7	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
stained	NULL
with	NULL
Wright-Giemsa	NULL
(	NULL
Diff	NULL
Quik	NULL
;	NULL
Baxter	NULL
Healthcare	NULL
Corp.	NULL
,	NULL
Deerfield	NULL
,	NULL
IL	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

Northem	NULL
Blot	NULL
Analysis	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
mouse	NULL
fetal	NULL
liver	NULL
,	NULL
adult	NULL
bone	NULL
marrow	NULL
,	NULL
spleen	NULL
,	NULL
thymus	NULL
,	NULL
and	NULL
peritoneal	NULL
cells	NULL
48	NULL
h	NULL
after	NULL
thioglycollate	NULL
stimulation	NULL
,	NULL
at	NULL
which	NULL
time	NULL
90	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
are	NULL
macrophages	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
purified	NULL
by	NULL
guanidine	NULL
iso-thiocyanate	NULL
extraction	NULL
and	NULL
cesium	NULL
chloride	NULL
gradient	NULL
.	NULL

Poly	NULL
A*	NULL
RNA	NULL
was	NULL
purified	NULL
by	NULL
oligo-	NULL
(	NULL
dT	NULL
)	NULL
chromatography	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
used	NULL
was	NULL
a	NULL
1.6-kb	NULL
Sacl	NULL
fragment	NULL
of	NULL
murine	NULL
IL-6	NULL
receptor	NULL
cDNA	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Quantitative	NULL
PCR	NULL
.	NULL

-	NULL
Quantitative	NULL
PCR	NULL
analysis	NULL
to	NULL
determine	NULL
receptor	NULL
mRNA	NULL
levels	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
33	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
purified	NULL
from	NULL
day	NULL
19	NULL
C/EBPa	NULL
wild-type	NULL
or	NULL
-/-	NULL
fetal	NULL
liver	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
of	NULL
plasmid	NULL
pSPCR	NULL
1	NULL
mRNA	NULL
was	NULL
used	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

The	NULL
standard	NULL
mRNA	NULL
concentration	NULL
was	NULL
measured	NULL
by	NULL
UV	NULL
absorption	NULL
after	NULL
purification	NULL
by	NULL
oligo-	NULL
(	NULL
dT	NULL
)	NULL
chromatography	NULL
.	NULL

The	NULL
length	NULL
of	NULL
the	NULL
IL-6	NULL
receptor	NULL
RNA	NULL
molecules	NULL
obtained	NULL
from	NULL
transcription	NULL
of	NULL
pSPCR	NULL
1	NULL
as	NULL
the	NULL
template	NULL
was	NULL
520	NULL
bp	NULL
,	NULL
and	NULL
1	NULL
jug	NULL
of	NULL
RNA	NULL
equals	NULL
1.76	NULL
X	NULL
10	NULL
``	NULL
molecules	NULL
.	NULL

First-strand	NULL
cDNA	NULL
from	NULL
fetal	NULL
liver	NULL
RNA	NULL
was	NULL
synthesized	NULL
by	NULL
reverse	NULL
transcription	NULL
(	NULL
RT	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
Corp.	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
contained	NULL
2	NULL
jpg	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
and	NULL
decreasing	NULL
amounts	NULL
of	NULL
standard	NULL
RNA	NULL
starting	NULL
at	NULL
10°	NULL
molecules	NULL
.	NULL

1	NULL
pl	NULL
of	NULL
RT	NULL
product	NULL
was	NULL
used	NULL
for	NULL
PCR	NULL
.	NULL

The	NULL
annealing	NULL
temperature	NULL
for	NULL
G-CSF	NULL
receptor	NULL
was	NULL
52°C	NULL
;	NULL
for	NULL
the	NULL
IL-6	NULL
receptor	NULL
,	NULL
52°C	NULL
;	NULL
and	NULL
for	NULL
IL-6	NULL
and	NULL
G-CSF	NULL
Receptors	NULL
in	NULL
Granulopoiesis	NULL
gp130	NULL
,	NULL
54°C	NULL
.	NULL

The	NULL
oligonucleotides	NULL
used	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
for	NULL
the	NULL
IL-6	NULL
receptor	NULL
,	NULL
5'-primer	NULL
,	NULL
ACCACGAGGATCAGTACGAA	NULL
,	NULL
and	NULL
3'-primer	NULL
,	NULL
TGTTGTCATAAGGGCTCTGT	NULL
;	NULL
for	NULL
gp130	NULL
,	NULL
5'-primer	NULL
,	NULL
TTGAAGTCTGGGTGGAAGCA	NULL
,	NULL
and	NULL
3'-primer	NULL
,	NULL
GGTGGTCTGGATGGTCTGTC	NULL
;	NULL
for	NULL
the	NULL
G-CSF	NULL
receptor	NULL
,	NULL
5'-primer	NULL
,	NULL
TCCGTCACCCTAAACATCTC	NULL
,	NULL
and	NULL
3'-primer	NULL
,	NULL
TGGAAGGTTTCCTCTGTCAT	NULL
.	NULL

PCR	NULL
amplification	NULL
was	NULL
continued	NULL
for	NULL
30	NULL
cycles	NULL
.	NULL

5	NULL
pl	NULL
of	NULL
each	NULL
PCR	NULL
product	NULL
was	NULL
electrophoresed	NULL
in	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
1	NULL
X	NULL
TBE	NULL
buffer	NULL
.	NULL

Quantita-tion	NULL
of	NULL
autoradiography	NULL
of	NULL
dried	NULL
gels	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
PhosphorImager	NULL
and	NULL
ImageQuant	NULL
densitometry	NULL
software	NULL
(	NULL
Molec-ular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Flow	NULL
Cytometry	NULL
(	NULL
FACS®	NULL
)	NULL
.	NULL

Human	NULL
recombinant	NULL
G-CSF	NULL
and	NULL
IL-6	NULL
were	NULL
biotinylated	NULL
by	NULL
using	NULL
NHS-LC-biotin	NULL
(	NULL
Pierce	NULL
Chemical	NULL
Co.	NULL
,	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
procedure	NULL
.	NULL

Single	NULL
cell	NULL
suspensions	NULL
of	NULL
fetal	NULL
liver	NULL
and	NULL
spleen	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
and	NULL
then	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
1	NULL
h	NULL
with	NULL
biotinylated	NULL
G-CSF	NULL
(	NULL
25	NULL
ng/	NULL
10°	NULL
cells	NULL
)	NULL
or	NULL
IL-6	NULL
(	NULL
25	NULL
ng/	NULL
10°	NULL
cells	NULL
)	NULL
.	NULL

After	NULL
washing	NULL
twice	NULL
with	NULL
PBS	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
PE-con-jugated	NULL
streptavidin	NULL
.	NULL

Cells	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
FACScan®	NULL
flow	NULL
cytometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

G-CSF	NULL
and	NULL
IL-6	NULL
(	NULL
without	NULL
biotinylation	NULL
)	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
.	NULL

Retrovius	NULL
Infetion	NULL
of	NULL
G-CSF	NULL
Receptor-expressing	NULL
Retrovimuses	NULL
.	NULL

For	NULL
retroviral	NULL
transduction	NULL
experiments	NULL
,	NULL
the	NULL
murine	NULL
G-CSF	NULL
receptor	NULL
cDNA	NULL
(	NULL
the	NULL
EcoRI/	NULL
Xhol	NULL
fragment	NULL
)	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
MND-X-SN	NULL
retroviral	NULL
plasmid	NULL
(	NULL
34	NULL
)	NULL
.	NULL

This	NULL
construct	NULL
was	NULL
stably	NULL
transfected	NULL
into	NULL
the	NULL
GP+E86	NULL
packaging	NULL
cell	NULL
line	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
HXM	NULL
(	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
15	NULL
g/	NULL
ml	NULL
of	NULL
hy-poxanthine	NULL
,	NULL
250	NULL
pg/ml	NULL
xanthine	NULL
,	NULL
25	NULL
g/	NULL
ml	NULL
mycophenolic	NULL
acid	NULL
)	NULL
and	NULL
0.8	NULL
mg/ml	NULL
6418	NULL
.	NULL

The	NULL
titer	NULL
of	NULL
the	NULL
retrovirus	NULL
from	NULL
this	NULL
pro	NULL
ducer	NULL
line	NULL
was	NULL
5	NULL
X	NULL
10°	NULL
PFU/	NULL
ml	NULL
.	NULL

For	NULL
infection	NULL
of	NULL
fetal	NULL
liver	NULL
,	NULL
producer	NULL
cells	NULL
were	NULL
plated	NULL
the	NULL
day	NULL
before	NULL
cocultivation	NULL
.	NULL

The	NULL
following	NULL
day	NULL
,	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
80-90	NULL
%	NULL
confluent	NULL
,	NULL
they	NULL
were	NULL
irradiated	NULL
with	NULL
a	NULL
single	NULL
dose	NULL
of	NULL
3,000	NULL
rad	NULL
from	NULL
a	NULL
``	NULL
Cs	NULL
source	NULL
.	NULL

Single	NULL
cell	NULL
suspensions	NULL
from	NULL
C/	NULL
EBPa	NULL
wild-type	NULL
,	NULL
+/-	NULL
,	NULL
or	NULL
-/	NULL
-	NULL
fetal	NULL
livers	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
.	NULL

After	NULL
lysis	NULL
of	NULL
red	NULL
blood	NULL
cells	NULL
with	NULL
ACK	NULL
(	NULL
0.15	NULL
M	NULL
MH	NULL
,	NULL
Cl	NULL
,	NULL
1.0	NULL
mM	NULL
KHCO	NULL
;	NULL
,	NULL
0.1	NULL
mM	NULL
NaEDTA	NULL
,	NULL
pH	NULL
7.3	NULL
)	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
IMDM	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
SCF	NULL
(	NULL
Chinese	NULL
hamster	NULL
ovary	NULL
cell	NULL
conditioned-medium	NULL
)	NULL
and	NULL
8	NULL
g/	NULL
ml	NULL
polybrene	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
divided	NULL
into	NULL
two	NULL
cultures	NULL
,	NULL
one	NULL
with	NULL
retrovirus	NULL
producer	NULL
cells	NULL
,	NULL
one	NULL
without	NULL
.	NULL

20	NULL
h	NULL
later	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
plated	NULL
in	NULL
methylcellulose	NULL
.	NULL

Results	NULL
C/EBPa'-	NULL
Murine	NULL
Myeloid	NULL
Progenitors	NULL
Do	NULL
Not	NULL
Respond	NULL
to	NULL
IL-6	NULL
.	NULL

-	NULL
Because	NULL
of	NULL
the	NULL
differences	NULL
in	NULL
phenotype	NULL
between	NULL
C/EBPa	NULL
«	NULL
~'-	NULL
and	NULL
G-CSF	NULL
receptor-	NULL
mice	NULL
,	NULL
we	NULL
suspected	NULL
that	NULL
other	NULL
cytokine	NULL
signaling	NULL
pathways	NULL
in	NULL
addition	NULL
to	NULL
G-CSF	NULL
may	NULL
be	NULL
adversely	NULL
affected	NULL
in	NULL
C/EBP	NULL
«	NULL
~'~	NULL
mice	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
investigate	NULL
the	NULL
response	NULL
of	NULL
C/	NULL
EBPa-deficient	NULL
cells	NULL
to	NULL
various	NULL
cytokines	NULL
,	NULL
methylcellulose	NULL
CFU	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
liver	NULL
hematopoietic	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
the	NULL
total	NULL
colony	NULL
numbers	NULL
from	NULL
-/-	NULL
mice	NULL
are	NULL
quantitatively	NULL
equal	NULL
to	NULL
those	NULL
from	NULL
wild-type	NULL
mice	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
.	NULL

We	NULL
also	NULL
observed	NULL
mature	NULL
granulocytes	NULL
in	NULL
colonies	NULL
derived	NULL
from	NULL
C/EBPa	NULL
«	NULL
~'~	NULL
mice	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-3	NULL
or	NULL
GM-CSF	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
Table	NULL
1	NULL
.	NULL

_	NULL
In	NULL
Vit	NULL
Hematopoiesis	NULL
and	NULL
Differentiation	NULL
of	NULL
Wild-type	NULL
and	NULL
C/	NULL
EBPa_	NULL
'	NULL
~-	NULL
Cells	NULL
Colonies	NULL
CSF	NULL
Wild-type	NULL
-/-	NULL
Segmented	NULL
neutrophils	NULL
%	NULL
wild-type	NULL
IL-6	NULL
134	NULL
+	NULL
25	NULL
2.0	NULL
+	NULL
1.4	NULL
<	NULL
1	NULL
IL-6	NULL
+	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
200	NULL
+	NULL
49	NULL
26	NULL
+	NULL
11	NULL
3.4	NULL
+	NULL
1.8	NULL
IL-6	NULL
+	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
+	NULL
G-CSF	NULL
266	NULL
+	NULL
50	NULL
82	NULL
+	NULL
40	NULL
12	NULL
+	NULL
4.8	NULL
G-CSF	NULL
150	NULL
+	NULL
70	NULL
0.5	NULL
+	NULL
1	NULL
<	NULL
1	NULL
G-CSF	NULL
+	NULL
G-CSF	NULL
receptor	NULL
148	NULL
+	NULL
66	NULL
63	NULL
+	NULL
28	NULL
66	NULL
+	NULL
26	NULL
IL-6	NULL
+	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
+	NULL
G-CSF	NULL
227	NULL
+	NULL
58	NULL
37	NULL
+	NULL
11	NULL
39	NULL
+	NULL
23	NULL
IL-6	NULL
+	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
+	NULL
G-CSF	NULL
+	NULL
G-CSF	NULL
receptor	NULL
retrovirus	NULL
192	NULL
+	NULL
23	NULL
46	NULL
+	NULL
11	NULL
84	NULL
+	NULL
12	NULL
IL-3	NULL
249	NULL
+	NULL
25	NULL
217	NULL
+	NULL
86	NULL
35	NULL
+	NULL
18	NULL
GM-CSF	NULL
181	NULL
+	NULL
81	NULL
163	NULL
+	NULL
57	NULL
40	NULL
+	NULL
5.7	NULL
Fetal	NULL
liver	NULL
cells	NULL
(	NULL
10°	NULL
cells	NULL
for	NULL
CFU-G	NULL
and	NULL
CFU-IL6	NULL
,	NULL
and	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
for	NULL
CFU-IL3	NULL
and	NULL
CFU-GM	NULL
)	NULL
were	NULL
plated	NULL
in	NULL
methylcellulose	NULL
medium	NULL
containing	NULL
the	NULL
indicated	NULL
cytokines	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
cytokines	NULL
is	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Colonies	NULL
containing	NULL
>	NULL
50	NULL
cells	NULL
were	NULL
counted	NULL
after	NULL
6-7	NULL
d.	NULL
Three	NULL
to	NULL
five	NULL
animals	NULL
of	NULL
each	NULL
genotype	NULL
were	NULL
analyzed	NULL
.	NULL

Wild-type	NULL
animals	NULL
(	NULL
+/+	NULL
)	NULL
gave	NULL
a	NULL
result	NULL
similar	NULL
to	NULL
that	NULL
obtained	NULL
from	NULL
heterozygous	NULL
animals	NULL
(	NULL
+/-	NULL
)	NULL
.	NULL

The	NULL
number	NULL
of	NULL
CFU	NULL
-IL6	NULL
from	NULL
C/	NULL
EBPa~~	NULL
livers	NULL
was	NULL
derived	NULL
from	NULL
only	NULL
three	NULL
colonies	NULL
in	NULL
one	NULL
plate	NULL
,	NULL
which	NULL
morphologically	NULL
showed	NULL
all	NULL
macrophages	NULL
after	NULL
cytocentrifugation	NULL
of	NULL
the	NULL
colonies	NULL
onto	NULL
slides	NULL
and	NULL
staining	NULL
with	NULL
Wright-Giemsa	NULL
.	NULL

Differential	NULL
counts	NULL
were	NULL
performed	NULL
as	NULL
follows	NULL
:	NULL
two	NULL
to	NULL
four	NULL
colonies	NULL
were	NULL
pooled	NULL
from	NULL
each	NULL
plate	NULL
on	NULL
two	NULL
successive	NULL
days	NULL
and	NULL
cytocentrifuged	NULL
onto	NULL
glass	NULL
slides	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
stained	NULL
with	NULL
Diff-Quik	NULL
solution	NULL
.	NULL

The	NULL
percentages	NULL
of	NULL
segmented	NULL
granulocytes	NULL
were	NULL
determined	NULL
by	NULL
counting	NULL
200-300	NULL
cells	NULL
from	NULL
each	NULL
slide	NULL
,	NULL
and	NULL
calculating	NULL
the	NULL
percentage	NULL
of	NULL
granulocytes	NULL
in	NULL
knockout	NULL
colonies	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
wild-type	NULL
.	NULL

Each	NULL
number	NULL
was	NULL
derived	NULL
from	NULL
3	NULL
to	NULL
4	NULL
individual	NULL
animals	NULL
and	NULL
a	NULL
total	NULL
of	NULL
at	NULL
least	NULL
16	NULL
colonies	NULL
for	NULL
CFU-G	NULL
and	NULL
CFU-IL6	NULL
.	NULL

1175	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

Table	NULL
2	NULL
.	NULL

-	NULL
Differential	NULL
Counts	NULL
of	NULL
CFU	NULL
Assays	NULL
Growth	NULL
factor	NULL
Genotype	NULL
Segmented	NULL
neutrophils	NULL
Macrophage	NULL
Immature	NULL
%	NULL
%	NULL
%	NULL
GM-CSF	NULL
+/-	NULL
53.8	NULL
+	NULL
13.8	NULL
6.5	NULL
+	NULL
3.5	NULL
39.8	NULL
+	NULL
10.2	NULL
-/-	NULL
20.7	NULL
+	NULL
2.3	NULL
7.2	NULL
+	NULL
#	NULL
1.9	NULL
72.2	NULL
+	NULL
0.8	NULL
IL-3	NULL
+/-	NULL
51.0	NULL
+	NULL
6.2	NULL
11.7	NULL
+	NULL
1.5	NULL
40.7	NULL
+	NULL
4.9	NULL
-/-	NULL
17.3	NULL
+	NULL
7.0	NULL
7.2	NULL
+	NULL
3.3	NULL
75.5	NULL
+	NULL
10.3	NULL
IL-6	NULL
+	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
+/-	NULL
38.7	NULL
+	NULL
8.4	NULL
33.0	NULL
+	NULL
6.3	NULL
28.3	NULL
+	NULL
2.3	NULL
-/-	NULL
1.2	NULL
+	NULL
0.3	NULL
48.3	NULL
+	NULL
8.7	NULL
50.5	NULL
+	NULL
9.0	NULL
G-CSF	NULL
+	NULL
G-CSF	NULL
receptor	NULL
+/-	NULL
43.0	NULL
+	NULL
14.7	NULL
23.1	NULL
+	NULL
11.7	NULL
34.3	NULL
+	NULL
3.3	NULL
-/-	NULL
26.0	NULL
+	NULL
5.4	NULL
22.3	NULL
+	NULL
7.6	NULL
51.7	NULL
+	NULL
3.3	NULL
G-CSF	NULL
+	NULL
IL-6	NULL
+	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
+/-	NULL
46.1	NULL
+	NULL
9.4	NULL
31.6	NULL
+	NULL
11.4	NULL
22.3	NULL
+	NULL
4.6	NULL
-/-	NULL
16.5	NULL
+	NULL
6.4	NULL
37.2	NULL
+	NULL
6.8	NULL
46.3	NULL
+	NULL
8.1	NULL
G-CSF	NULL
+	NULL
IL-6	NULL
+	NULL
G-CSF	NULL
receptor	NULL
+	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
+/-	NULL
48.7	NULL
+	NULL
8.7	NULL
33.1	NULL
+	NULL
2.5	NULL
18.1	NULL
+	NULL
11.4	NULL
-/-	NULL
40.6	NULL
+	NULL
5.5	NULL
33.3	NULL
+	NULL
7.0	NULL
22.5	NULL
+	NULL
8.3	NULL
Using	NULL
the	NULL
colonies	NULL
generated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Table	NULL
1	NULL
,	NULL
percentages	NULL
of	NULL
different	NULL
types	NULL
of	NULL
cells	NULL
were	NULL
determined	NULL
by	NULL
counting	NULL
200-300	NULL
cells	NULL
from	NULL
each	NULL
slide	NULL
.	NULL

Each	NULL
number	NULL
was	NULL
derived	NULL
from	NULL
a	NULL
total	NULL
of	NULL
3	NULL
to	NULL
4	NULL
individual	NULL
animals	NULL
,	NULL
and	NULL
at	NULL
least	NULL
16	NULL
colonies	NULL
for	NULL
CFU-G	NULL
and	NULL
CFU-IL6	NULL
.	NULL

Immature	NULL
cells	NULL
include	NULL
myeloblasts	NULL
and	NULL
metamyelocytes	NULL
;	NULL
segmented	NULL
neutrophils	NULL
include	NULL
band	NULL
forms	NULL
.	NULL

percentage	NULL
of	NULL
segmented	NULL
neutrophils	NULL
in	NULL
IL-3-responsive	NULL
CFU	NULL
(	NULL
CFU-IL3	NULL
)	NULL
and	NULL
CFU-GM-CSF	NULL
derived	NULL
from	NULL
C/	NULL
EBPa	NULL
«	NULL
-	NULL
'	NULL
-	NULL
fetal	NULL
liver	NULL
is	NULL
much	NULL
lower	NULL
than	NULL
those	NULL
from	NULL
wild-type	NULL
mice	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
myeloblasts	NULL
in	NULL
C/	NULL
EBPa	NULL
«	NULL
~'~	NULL
mice	NULL
is	NULL
much	NULL
higher	NULL
than	NULL
in	NULL
wild-type	NULL
mice	NULL
in	NULL
CFU	NULL
assays	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Table	NULL
2	NULL
.	NULL

In	NULL
cultures	NULL
of	NULL
C/EBPa	NULL
wild-type	NULL
hematopoietic	NULL
progenitors	NULL
,	NULL
IL-6-stimulated	NULL
colonies	NULL
contained	NULL
immature	NULL
and	NULL
mature	NULL
granulocytic	NULL
cells	NULL
and	NULL
mature	NULL
macrophages	NULL
.	NULL

However	NULL
,	NULL
C/	NULL
EBPa-deficient	NULL
cells	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
IL-6	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
C/EBPa-~'-	NULL
mice	NULL
have	NULL
myeloid	NULL
precursors	NULL
that	NULL
responded	NULL
to	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
in	NULL
vitro	NULL
,	NULL
but	NULL
that	NULL
there	NULL
is	NULL
no	NULL
such	NULL
population	NULL
that	NULL
responded	NULL
to	NULL
IL-6	NULL
.	NULL

Mutation	NULL
of	NULL
C/	NULL
EBPa	NULL
Results	NULL
in	NULL
Drastically	NULL
Deceased	NULL
Expression	NULL
of	NULL
IL-6	NULL
Receptor	NULL
and	NULL
G-CSF	NULL
Reaeptor	NULL
mRNA	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
IL-6	NULL
receptor	NULL
expression	NULL
is	NULL
defective	NULL
in	NULL
C/EBP	NULL
«	NULL
~'~	NULL
mice	NULL
,	NULL
we	NULL
first	NULL
performed	NULL
Northern	NULL
blot	NULL
analysis	NULL
As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
,	NULL
IL-6	NULL
receptor	NULL
mRNA	NULL
was	NULL
detected	NULL
from	NULL
the	NULL
liver	NULL
of	NULL
day	NULL
19	NULL
C/EBPa	NULL
«	NULL
*'~	NULL
embryos	NULL
.	NULL

The	NULL
signal	NULL
is	NULL
weaker	NULL
than	NULL
that	NULL
detected	NULL
in	NULL
RNA	NULL
from	NULL
adult	NULL
bone	NULL
marrow	NULL
,	NULL
peritoneal	NULL
cells	NULL
after	NULL
thioglycollate	NULL
stimulation	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
liver	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
did	NULL
not	NULL
detect	NULL
any	NULL
hybridization	NULL
from	NULL
total	NULL
RNA	NULL
from	NULL
the	NULL
liver	NULL
of	NULL
day	NULL
19	NULL
C/EBPa	NULL
«	NULL
~'~	NULL
embryos	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
could	NULL
detect	NULL
IL-6	NULL
receptor	NULL
using	NULL
poly	NULL
A*	NULL
mRNA	NULL
from	NULL
the	NULL
liver	NULL
of	NULL
-/-	NULL
day	NULL
19	NULL
embryos	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

To	NULL
quantitate	NULL
the	NULL
expression	NULL
level	NULL
of	NULL
IL-6	NULL
receptor	NULL
mRNA	NULL
,	NULL
we	NULL
performed	NULL
quantitative	NULL
PCR	NULL
using	NULL
RNA	NULL
from	NULL
livers	NULL
of	NULL
C/EBP	NULL
«	NULL
~'~	NULL
and	NULL
wild-type	NULL
mice	NULL
.	NULL

The	NULL
results	NULL
of	NULL
the	NULL
quantitative	NULL
PCR	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
.	NULL

The	NULL
number	NULL
of	NULL
IL-6	NULL
receptor	NULL
molecules	NULL
per	NULL
microgram	NULL
of	NULL
total	NULL
liver	NULL
RNA	NULL
from	NULL
wild-type	NULL
mice	NULL
was	NULL
very	NULL
similar	NULL
to	NULL
that	NULL
published	NULL
previ-	NULL
1176	NULL
ously	NULL
(	NULL
33	NULL
)	NULL
.	NULL

The	NULL
number	NULL
of	NULL
IL-6	NULL
receptor	NULL
mRNA	NULL
molecules	NULL
was	NULL
dramatically	NULL
reduced	NULL
in	NULL
-/-	NULL
mice	NULL
,	NULL
170-fold	NULL
lower	NULL
than	NULL
in	NULL
wild-type	NULL
animals	NULL
The	NULL
number	NULL
of	NULL
gp130	NULL
molecules	NULL
from	NULL
-/	NULL
-	NULL
mice	NULL
was	NULL
comparable	NULL
to	NULL
the	NULL
number	NULL
found	NULL
in	NULL
wild-type	NULL
mice	NULL
,	NULL
and	NULL
the	NULL
number	NULL
of	NULL
G-CSF	NULL
receptor	NULL
molecules	NULL
from	NULL
-/-	NULL
livers	NULL
was	NULL
17-fold	NULL
lower	NULL
than	NULL
in	NULL
wild-type	NULL
livers	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
further	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
C/	NULL
EBPa	NULL
regulates	NULL
G-CSF	NULL
receptor	NULL
not	NULL
only	NULL
in	NULL
vitro	NULL
(	NULL
5	NULL
)	NULL
,	NULL
but	NULL
also	NULL
in	NULL
vivo	NULL
.	NULL

Our	NULL
results	NULL
also	NULL
suggest	NULL
that	NULL
C/	NULL
EBPa	NULL
directly	NULL
or	NULL
indirectly	NULL
regulates	NULL
IL-6	NULL
receptor	NULL
but	NULL
not	NULL
gp130	NULL
mRNA	NULL
expression	NULL
in	NULL
vivo	NULL
.	NULL

Hematopoietic	NULL
Cells	NULL
in	NULL
C/EBP	NULL
Mutant	NULL
Mic	NULL
Have	NULL
Undetectable	NULL
IL-6	NULL
Receptor	NULL
and	NULL
G-CSF	NULL
Receptor	NULL
Protein	NULL
Levels	NULL
.	NULL

O	NULL
ur	NULL
quantitative	NULL
PCR	NULL
results	NULL
demonstrated	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
G-CSF	NULL
receptor	NULL
and	NULL
IL-6	NULL
receptor	NULL
mRNA	NULL
,	NULL
and	NULL
showed	NULL
that	NULL
progenitor	NULL
cells	NULL
from	NULL
mice	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
G-CSF	NULL
and	NULL
IL-6	NULL
in	NULL
vitro	NULL
or	NULL
in	NULL
vivo	NULL
(	NULL
18	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
protein	NULL
levels	NULL
of	NULL
IL-6	NULL
receptor	NULL
and	NULL
G-CSF	NULL
receptor	NULL
expression	NULL
,	NULL
hematopoietic	NULL
cells	NULL
from	NULL
the	NULL
liver	NULL
of	NULL
C/	NULL
EBPa	NULL
wild-type	NULL
and	NULL
-/-	NULL
mice	NULL
were	NULL
labeled	NULL
separately	NULL
with	NULL
biotinylated	NULL
G-CSF	NULL
and	NULL
IL-6	NULL
followed	NULL
by	NULL
PE-con-jugated	NULL
streptavidin	NULL
.	NULL

After	NULL
staining	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
FACS®	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
,	NULL
C	NULL
,	NULL
and	NULL
E	NULL
,	NULL
G-CSF	NULL
receptor-positive	NULL
and	NULL
IL-6	NULL
receptor-positive	NULL
cell	NULL
populations	NULL
are	NULL
easily	NULL
detected	NULL
in	NULL
C/EBPa*'~	NULL
fetal	NULL
liver	NULL
and	NULL
spleen	NULL
,	NULL
but	NULL
there	NULL
are	NULL
no	NULL
such	NULL
populations	NULL
detected	NULL
in	NULL
-/	NULL
-	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
B	NULL
,	NULL
D	NULL
,	NULL
and	NULL
F	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
G-CSF	NULL
receptor	NULL
and	NULL
IL-6	NULL
receptor	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
C/EBPa	NULL
«	NULL
_'-cells	NULL
is	NULL
undetectable	NULL
.	NULL

The	NULL
number	NULL
of	NULL
G-CSF	NULL
receptors	NULL
on	NULL
mature	NULL
granulocytes	NULL
is	NULL
much	NULL
higher	NULL
than	NULL
on	NULL
immature	NULL
myeloid	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
,	NULL
and	NULL
C/	NULL
EBPa-~'-	NULL
animals	NULL
do	NULL
not	NULL
make	NULL
mature	NULL
granulocytes	NULL
One	NULL
possible	NULL
explanation	NULL
for	NULL
the	NULL
low	NULL
level	NULL
of	NULL
G-CSF	NULL
receptors	NULL
detected	NULL
in	NULL
C/EBP	NULL
«	NULL
~'-	NULL
mice	NULL
is	NULL
IL-6	NULL
and	NULL
G-CSF	NULL
Receptors	NULL
in	NULL
Granulopoiesis	NULL
+/-	NULL
CFU-IL3	NULL
-/-3	NULL
Lan	NULL
.	NULL

Figure	NULL
1	NULL
.	NULL

_	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
can	NULL
stimulate	NULL
C/EBPa~~	NULL
fetal	NULL
liver	NULL
cells	NULL
to	NULL
differentiate	NULL
to	NULL
mature	NULL
granulocytes	NULL
.	NULL

(	NULL
A-D	NULL
)	NULL
Representative	NULL
views	NULL
of	NULL
cells	NULL
from	NULL
colonies	NULL
obtained	NULL
in	NULL
CFU	NULL
assays	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
from	NULL
C/EBPa*	NULL
``	NULL
~	NULL
(	NULL
A	NULL
and	NULL
C	NULL
)	NULL
and	NULL
-/	NULL
-	NULL
(	NULL
B	NULL
and	NULL
D	NULL
)	NULL
fetal	NULL
liver	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
or	NULL
IL-3	NULL
after	NULL
7	NULL
d	NULL
in	NULL
methylcellulose	NULL
culture	NULL
.	NULL

Two	NULL
to	NULL
three	NULL
colonies	NULL
from	NULL
each	NULL
plate	NULL
were	NULL
pooled	NULL
,	NULL
cytocentrifuged	NULL
onto	NULL
slides	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
Wright-Giemsa	NULL
.	NULL

(	NULL
E	NULL
and	NULL
F	NULL
)	NULL
The	NULL
same	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
liquid	NULL
culture	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-3	NULL
and	NULL
SCF	NULL
for	NULL
5	NULL
d.	NULL
E	NULL
shows	NULL
cells	NULL
derived	NULL
from	NULL
+/-	NULL
mice	NULL
,	NULL
and	NULL
F	NULL
from	NULL
-/-	NULL
mice	NULL
.	NULL

Identical	NULL
results	NULL
were	NULL
obtained	NULL
after	NULL
culture	NULL
with	NULL
GM-CSF	NULL
.	NULL

We	NULL
were	NULL
also	NULL
not	NULL
able	NULL
to	NULL
distinguish	NULL
differences	NULL
between	NULL
cells	NULL
obtained	NULL
from	NULL
wild-type	NULL
and	NULL
heterozygous	NULL
animals	NULL
in	NULL
any	NULL
of	NULL
the	NULL
experiments	NULL
in	NULL
this	NULL
study	NULL
.	NULL

£	NULL
5	NULL
&	NULL
5	NULL
%	NULL
Figure	NULL
2	NULL
.	NULL

IL-6	NULL
_	NULL
receptor	NULL
Total	NULL
RNA	NULL
__	NULL
Poly	NULL
A	NULL
B	NULL
n	NULL
$	NULL
$	NULL
4	NULL
$	NULL
&	NULL
_	NULL
8	NULL
P	NULL
A	NULL
r	NULL
(	NULL
u_|	NULL
|	NULL
$	NULL
|	NULL
£27	NULL
2	NULL
<	NULL
3	NULL
S	NULL
og	NULL
S	NULL
mRNA	NULL
is	NULL
markedly	NULL
decreased	NULL
in	NULL
y	NULL
C	NULL
l	NULL
“	NULL
:	NULL
ig	NULL
g	NULL
:	NULL
T	NULL
v	NULL
:	NULL
tug	NULL
c	NULL
“	NULL
:	NULL
C/EBPa~'~	NULL
mice	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Northern	NULL
4T	NULL
tan	NULL
:	NULL
-	NULL
565	NULL
m	NULL
rh	NULL
wir	NULL
)	NULL
mond	NULL
ag	NULL
omi	NULL
ae	NULL
}	NULL
blot	NULL
analysis	NULL
of	NULL
IL-6	NULL
receptor	NULL
IL-6R	NULL
>	NULL
«	NULL
w	NULL
~-	NULL
Northern	NULL
Quantitative	NULL
mRNA	NULL
.	NULL

15	NULL
pug	NULL
of	NULL
total	NULL
RNA	NULL
Stand	NULL
arc-	NULL
-	NULL
tip	NULL
opy	NULL
uy	NULL
lle	NULL
from	NULL
C/EBPa	NULL
«	NULL
*~	NULL
day	NULL
19	NULL
fetal	NULL
-	NULL
13s	NULL
Biot	NULL
1L-68	NULL
-	NULL
Cex	NULL
**	NULL
RT-PCR	NULL
liver	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
and	NULL
C/EBPo	NULL
--	NULL
5	NULL
;	NULL
day	NULL
19	NULL
fetal	NULL
liver	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
and	NULL
2	NULL
18s	NULL
>	NULL
.	NULL

-	NULL
@	NULL
»	NULL
<	NULL
-caron	NULL
L	NULL
iL	NULL
j	NULL
ug	NULL
of	NULL
poly	NULL
A*	NULL
RNA	NULL
from	NULL
C/	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Genotype	NULL
+/+	NULL
Ms	NULL
EBPa*~	NULL
day	NULL
19	NULL
fetal	NULL
liver	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
-/-	NULL
day	NULL
19	NULL
fetal	NULL
liver	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
were	NULL
electrophoresed	NULL
in	NULL
1	NULL
%	NULL
agarose/	NULL
formaldehyde	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
a	NULL
murine	NULL
IL-6	NULL
receptor	NULL
cDNA	NULL
(	NULL
reference	NULL
26	NULL
)	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
IL-6	NULL
receptor	NULL
mR	NULL
N	NULL
As	NULL
(	NULL
/g	NULL
?	NULL
)	NULL

and	NULL
the	NULL
288	NULL
and	NULL
18	NULL
$	NULL
RNAs	NULL
(	NULL
right	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

Below	NULL
the	NULL
total	NULL
RNA	NULL
blot	NULL
(	NULL
Ig	NULL
?	NULL
)	NULL

are	NULL
shown	NULL
the	NULL
results	NULL
of	NULL
hybridization	NULL
of	NULL
an	NULL
188	NULL
ribosomal	NULL
RN	NULL
A	NULL
oligonucleotide	NULL
to	NULL
the	NULL
blot	NULL
(	NULL
5-TCGGGCCTGCTTTGAACA-3	NULL
'	NULL
[	NULL
reference	NULL
51	NULL
]	NULL
)	NULL
,	NULL
and	NULL
below	NULL
the	NULL
poly	NULL
A*	NULL
blot	NULL
(	NULL
right	NULL
)	NULL
are	NULL
shown	NULL
the	NULL
results	NULL
of	NULL
hybridization	NULL
of	NULL
a	NULL
GAPDH	NULL
probe	NULL
(	NULL
reference	NULL
52	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Quantitative	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
IL-6	NULL
receptor	NULL
mRNA	NULL
.	NULL

Above	NULL
the	NULL
autoradiograph	NULL
are	NULL
indicated	NULL
the	NULL
numbers	NULL
of	NULL
molecules	NULL
of	NULL
competitor	NULL
RNA	NULL
.	NULL

The	NULL
first	NULL
five	NULL
lanes	NULL
are	NULL
sample	NULL
RNAs	NULL
(	NULL
2	NULL
g/	NULL
lane	NULL
)	NULL
from	NULL
C/	NULL
EBPa	NULL
wild-type	NULL
fetal	NULL
liver	NULL
,	NULL
and	NULL
the	NULL
last	NULL
five	NULL
lanes	NULL
are	NULL
from	NULL
C/EBPa~~	NULL
fetal	NULL
liver	NULL
RNA	NULL
.	NULL

The	NULL
locations	NULL
of	NULL
the	NULL
standard	NULL
and	NULL
IL-6	NULL
receptor-amplified	NULL
PCR	NULL
prod	NULL
ucts	NULL
are	NULL
indicated	NULL
(	NULL
Igf	NULL
)	NULL
.	NULL

the	NULL
absence	NULL
of	NULL
mature	NULL
granulocytes	NULL
in	NULL
the	NULL
liver	NULL
and	NULL
spleen	NULL
.	NULL

Therefore	NULL
,	NULL
hematopoietic	NULL
cells	NULL
from	NULL
C/EBPa	NULL
heterozygous	NULL
and	NULL
-/-	NULL
fetal	NULL
liver	NULL
were	NULL
cultured	NULL
in	NULL
suspension	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SCF	NULL
and	NULL
IL-3	NULL
to	NULL
stimulate	NULL
both	NULL
heterozygous	NULL
and	NULL
-/	NULL
-	NULL
cells	NULL
towards	NULL
mature	NULL
granulocytic	NULL
differentiation	NULL
.	NULL

As	NULL
shown	NULL
below	NULL
,	NULL
SCF	NULL
alone	NULL
does	NULL
not	NULL
promote	NULL
granulocyte	NULL
differentiation	NULL
or	NULL
development	NULL
,	NULL
but	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cultures	NULL
to	NULL
promote	NULL
viability	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
other	NULL
growth	NULL
factors	NULL
After	NULL
5	NULL
d	NULL
in	NULL
culture	NULL
with	NULL
IL-3	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
cytocentrifuged	NULL
onto	NULL
slides	NULL
and	NULL
subsequently	NULL
stained	NULL
with	NULL
Wright-Giemsa	NULL
.	NULL

Mature	NULL
granulocytes	NULL
appeared	NULL
in	NULL
both	NULL
heterozygous	NULL
and	NULL
-/-	NULL
cultures	NULL
,	NULL
but	NULL
the	NULL
percentage	NULL
of	NULL
mature	NULL
granulocytes	NULL
in	NULL
heterozygous	NULL
cultures	NULL
was	NULL
higher	NULL
than	NULL
that	NULL
observed	NULL
in	NULL
the	NULL
-/-	NULL
cultures	NULL
,	NULL
similar	NULL
to	NULL
what	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
CFU	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
E	NULL
and	NULL
F	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
then	NULL
stained	NULL
with	NULL
biotinylated	NULL
G-CSF	NULL
and	NULL
IL-6	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
G-J	NULL
,	NULL
we	NULL
still	NULL
failed	NULL
to	NULL
observe	NULL
G-CSF	NULL
receptor	NULL
and	NULL
IL-6	NULL
receptor-positive	NULL
cells	NULL
from	NULL
-/-compared	NULL
with	NULL
wild-type	NULL
mice	NULL
,	NULL
even	NULL
after	NULL
culture	NULL
in	NULL
IL-3	NULL
induced	NULL
morphologic	NULL
maturation	NULL
in	NULL
which	NULL
~30	NULL
%	NULL
of	NULL
the	NULL
IL-6	NULL
IL-6	NULL
G-CSF	NULL
cells	NULL
were	NULL
metamyelocytes	NULL
or	NULL
segmented	NULL
granulocytes	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
although	NULL
mature	NULL
segmented	NULL
granulocytes	NULL
are	NULL
not	NULL
present	NULL
in	NULL
vivo	NULL
in	NULL
C/EBPa	NULL
mice	NULL
,	NULL
stimulation	NULL
of	NULL
C/EBP	NULL
«	NULL
~'~-	NULL
hematopoietic	NULL
cells	NULL
with	NULL
cytokines	NULL
like	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
can	NULL
induce	NULL
the	NULL
formation	NULL
of	NULL
cells	NULL
which	NULL
have	NULL
the	NULL
morphologic	NULL
appearance	NULL
of	NULL
mature	NULL
cells	NULL
yet	NULL
still	NULL
do	NULL
not	NULL
express	NULL
G-CSF	NULL
receptor	NULL
and	NULL
IL-6	NULL
receptor	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
absence	NULL
of	NULL
G-CSF	NULL
receptor	NULL
and	NULL
IL-6	NULL
receptor	NULL
is	NULL
not	NULL
simply	NULL
a	NULL
result	NULL
of	NULL
absence	NULL
of	NULL
mature	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
G-CSF	NULL
receptor	NULL
and	NULL
IL-6	NULL
receptor	NULL
are	NULL
truly	NULL
regu-lated	NULL
,	NULL
either	NULL
directly	NULL
or	NULL
indirectly	NULL
,	NULL
by	NULL
C/	NULL
EBPa	NULL
in	NULL
vivo	NULL
.	NULL

IL-6	NULL
and	NULL
Soluble	NULL
IL-6	NULL
Receptor	NULL
Together	NULL
Can	NULL
Rescue	NULL
C/	NULL
EBPa	NULL
Granulopotesis	NULL
In	NULL
Vitro	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
lack	NULL
of	NULL
IL-6	NULL
and	NULL
G-CSF	NULL
signaling	NULL
due	NULL
to	NULL
loss	NULL
of	NULL
both	NULL
IL-6	NULL
and	NULL
G-CSF	NULL
receptors	NULL
contributes	NULL
to	NULL
the	NULL
block	NULL
of	NULL
granulocyte	NULL
maturation	NULL
in	NULL
C/EBP	NULL
«	NULL
_'~-	NULL
mice	NULL
.	NULL

This	NULL
phenotype	NULL
could	NULL
potentially	NULL
be	NULL
rescued	NULL
by	NULL
restoration	NULL
of	NULL
the	NULL
receptors	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
the	NULL
cells	NULL
The	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
IL-6	NULL
receptor	NULL
is	NULL
not	NULL
required	NULL
for	NULL
IL-6	NULL
binding	NULL
and	NULL
signal	NULL
transduction	NULL
,	NULL
as	NULL
IL-6	NULL
can	NULL
bind	NULL
to	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
and	NULL
Figure	NULL
3	NULL
.	NULL

-	NULL
Flow	NULL
cytometry	NULL
analysis	NULL
with	NULL
biotinylated	NULL
IL-6	NULL
and	NULL
G-CSF	NULL
.	NULL

Cells	NULL
fom	NULL
C/EBPa*'~	NULL
(	NULL
A	NULL
and	NULL
C	NULL
)	NULL
or	NULL
C/EBPa	NULL
«	NULL
~~	NULL
(	NULL
B	NULL
and	NULL
D	NULL
)	NULL
day	NULL
17	NULL
fetal	NULL
liver	NULL
or	NULL
from	NULL
+/-	NULL
(	NULL
E	NULL
)	NULL
or	NULL
-/	NULL
(	NULL
F	NULL
)	NULL
day	NULL
17	NULL
fetal	NULL
spleen	NULL
were	NULL
stained	NULL
with	NULL
biotinylated	NULL
G-CSF	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
or	NULL
biotinylated	NULL
IL-6	NULL
(	NULL
C-F	NULL
)	NULL
.	NULL

Cells	NULL
IL-6	NULL
toms	NULL
#	NULL
)	NULL
(	NULL
me	NULL
is	NULL
mome	NULL
m	NULL
m	NULL
m	NULL
oro	NULL
a	NULL
from	NULL
C/EBPa*'~	NULL
(	NULL
G	NULL
and	NULL
7	NULL
)	NULL
or	NULL
C/	NULL
EBPe'~	NULL
(	NULL
H	NULL
and	NULL
J	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
IL-3	NULL
and	NULL
SCF	NULL
for	NULL
5	NULL
d	NULL
and	NULL
then	NULL
stained	NULL
with	NULL
biotinylated	NULL
G-CSF	NULL
(	NULL
G	NULL
and	NULL
H	NULL
)	NULL
or	NULL
biotinylated	NULL
IL-6	NULL
(	NULL
Z	NULL
and	NULL
C/EBP	NULL
+/-	NULL
J	NULL
)	NULL
.	NULL

b	NULL
,	NULL
The	NULL
FACS®	NULL
profiles	NULL
using	NULL
bi	NULL
soe	NULL
se	NULL
so	NULL
ie	NULL
otinylated	NULL
factor	NULL
(	NULL
G-CSF	NULL
or	NULL
IL-6	NULL
)	NULL
;	NULL
bar	NULL
,	NULL
the	NULL
profiles	NULL
using	NULL
unbiotinylated	NULL
factor	NULL
,	NULL
which	NULL
serves	NULL
as	NULL
a	NULL
con-trol	NULL
.	NULL

In	NULL
the	NULL
bottom	NULL
row	NULL
,	NULL
the	NULL
profiles	NULL
using	NULL
biotinylated	NULL
and	NULL
unbiotinylated	NULL
factor	NULL
are	NULL
superimposable	NULL
.	NULL

-/	NULL
Liver	NULL
cells	NULL
no	NULL
IL-3	NULL
Spleen	NULL
cells	NULL
1178	NULL
Liver	NULL
cells	NULL
with	NULL
IL-3	NULL
y-axis	NULL
,	NULL
Number	NULL
of	NULL
events	NULL
(	NULL
10,000	NULL
events	NULL
counted	NULL
in	NULL
each	NULL
panel	NULL
)	NULL
;	NULL
x-axis	NULL
,	NULL
log	NULL
;	NULL
,	NULL
fluorescence	NULL
.	NULL

IL-6	NULL
and	NULL
G-CSF	NULL
Receptors	NULL
in	NULL
Granulopoiesis	NULL
sIL6	NULL
receptor	NULL
+	NULL
IL6	NULL
+/-/	NULL
(	NULL
B	NULL
3\	NULL
g	NULL
,	NULL
9	NULL
+y	NULL
``	NULL
!	NULL

a	NULL
%	NULL
A	NULL
a	NULL
``	NULL
R	NULL
&	NULL
Fi	NULL
\	NULL
``	NULL
*	NULL
sIL6	NULL
receptor	NULL
+	NULL
IL6	NULL
+	NULL
G-CSF	NULL
G-CSF	NULL
receptor	NULL
+	NULL
G-CSF	NULL
Bog	NULL
(	NULL
sh	NULL
this	NULL
complex	NULL
can	NULL
trigger	NULL
gp130	NULL
to	NULL
transduce	NULL
a	NULL
signal	NULL
on	NULL
cells	NULL
that	NULL
lack	NULL
the	NULL
IL-6	NULL
receptor	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
fetal	NULL
liver	NULL
suspension	NULL
cells	NULL
from	NULL
both	NULL
wild-type	NULL
and	NULL
-/-	NULL
day	NULL
14	NULL
to	NULL
day	NULL
16	NULL
embryos	NULL
were	NULL
used	NULL
in	NULL
CFU	NULL
assays	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-6	NULL
plus	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
,	NULL
and	NULL
IL-6	NULL
plus	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
plus	NULL
G-CSF	NULL
,	NULL
respectively	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

There	NULL
were	NULL
significant	NULL
numbers	NULL
of	NULL
colonies	NULL
generated	NULL
from	NULL
wild-type	NULL
mice	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-6	NULL
plus	NULL
soluble	NULL
IL-6	NULL
receptors	NULL
which	NULL
were	NULL
morphologically	NULL
CFU-GM	NULL
.	NULL

When	NULL
G-CSF	NULL
was	NULL
also	NULL
added	NULL
,	NULL
both	NULL
the	NULL
colony	NULL
number	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
mature	NULL
granulocytes	NULL
increased	NULL
as	NULL
well	NULL
(	NULL
Tables	NULL
1	NULL
and	NULL
2	NULL
;	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Compared	NULL
with	NULL
those	NULL
from	NULL
wild-type	NULL
animals	NULL
,	NULL
the	NULL
colony	NULL
numbers	NULL
from	NULL
C/EBPa	NULL
«	NULL
~'~	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-6	NULL
and	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
were	NULL
lower	NULL
,	NULL
but	NULL
a	NULL
small	NULL
number	NULL
of	NULL
metamyelocytes	NULL
and	NULL
segmented	NULL
neutrophils	NULL
appeared	NULL
from	NULL
the	NULL
colonies	NULL
after	NULL
day	NULL
6	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
.	NULL

Most	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
-/-	NULL
colony	NULL
1179	NULL
_	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

&	NULL
j	NULL
$	NULL
043	NULL
.	NULL

4	NULL
.	NULL

J	NULL
Figure	NULL
4	NULL
.	NULL

-	NULL
Mature	NULL
granulocytes	NULL
are	NULL
observed	NULL
after	NULL
rescue	NULL
by	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
and	NULL
G-CSF	NULL
receptor	NULL
retrovirus	NULL
.	NULL

(	NULL
A	NULL
,	NULL
C	NULL
,	NULL
and	NULL
E	NULL
)	NULL
Cells	NULL
from	NULL
C/EBPa*~	NULL
fetal	NULL
liver	NULL
.	NULL

(	NULL
B	NULL
,	NULL
D	NULL
,	NULL
and	NULL
F	NULL
)	NULL
Cells	NULL
from	NULL
C/EBPa~~	NULL
fetal	NULL
liver	NULL
.	NULL

A	NULL
and	NULL
B	NULL
show	NULL
cells	NULL
from	NULL
CFU	NULL
assays	NULL
with	NULL
IL-6	NULL
and	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
in	NULL
the	NULL
medium	NULL
;	NULL
C	NULL
and	NULL
D	NULL
,	NULL
CFU	NULL
with	NULL
IL-6	NULL
,	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
,	NULL
and	NULL
G-CSF	NULL
in	NULL
the	NULL
medium	NULL
.	NULL

E	NULL
and	NULL
F	NULL
show	NULL
CFU	NULL
after	NULL
infection	NULL
of	NULL
fetal	NULL
liver	NULL
cells	NULL
with	NULL
the	NULL
G-CSF	NULL
receptor	NULL
retrovirus	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

5	NULL
followed	NULL
by	NULL
culture	NULL
in	NULL
methylcellulose	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
G-CSF	NULL
only	NULL
.	NULL

ofe	NULL
a	NULL
5	NULL
o5e	NULL
were	NULL
immature	NULL
cells	NULL
Interestingly	NULL
,	NULL
increases	NULL
in	NULL
colony	NULL
numbers	NULL
and	NULL
percentage	NULL
of	NULL
more	NULL
mature	NULL
segmented	NULL
granulocytes	NULL
were	NULL
observed	NULL
in	NULL
C/EBPa	NULL
«	NULL
~'~	NULL
mice	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
G-CSF	NULL
to	NULL
the	NULL
IL-6	NULL
plus	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
culture	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
D.	NULL
These	NULL
results	NULL
indicated	NULL
that	NULL
IL-6	NULL
plus	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
can	NULL
partially	NULL
rescue	NULL
the	NULL
C/	NULL
EBPa	NULL
phenotype	NULL
in	NULL
vitro	NULL
but	NULL
does	NULL
not	NULL
efficiently	NULL
induce	NULL
terminal	NULL
maturation	NULL
of	NULL
granulocytes	NULL
.	NULL

Restoration	NULL
of	NULL
G-CSF	NULL
Receptor	NULL
Expression	NULL
Can	NULL
Restore	NULL
the	NULL
Production	NULL
of	NULL
Mature	NULL
G	NULL
ranulocytes	NULL
In	NULL
V	NULL
itr	NULL
.	NULL

_	NULL
Granulocyte	NULL
maturation	NULL
was	NULL
completely	NULL
blocked	NULL
in	NULL
C/EBP	NULL
«	NULL
_'~-	NULL
mice	NULL
in	NULL
vivo	NULL
.	NULL

This	NULL
phenotype	NULL
can	NULL
only	NULL
be	NULL
partially	NULL
rescued	NULL
by	NULL
IL-6	NULL
signaling	NULL
in	NULL
vitro	NULL
.	NULL

Since	NULL
G-CSF	NULL
receptors	NULL
were	NULL
undetectable	NULL
in	NULL
C/EBPa	NULL
«	NULL
~'~	NULL
mice	NULL
,	NULL
rescue	NULL
experiments	NULL
were	NULL
performed	NULL
by	NULL
transduction	NULL
of	NULL
G-CSF	NULL
receptors	NULL
into	NULL
the	NULL
cells	NULL
using	NULL
retrovirus	NULL
infection	NULL
.	NULL

Day	NULL
15	NULL
fetal	NULL
liver	NULL
hematopoietic	NULL
cells	NULL
from	NULL
C/EBPa	NULL
«	NULL
~'-	NULL
and	NULL
heterozygous	NULL
mice	NULL
were	NULL
cul-	NULL
tured	NULL
with	NULL
or	NULL
without	NULL
murine	NULL
G-CSF	NULL
receptor	NULL
retrovirus	NULL
producer	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SCF	NULL
(	NULL
added	NULL
to	NULL
promote	NULL
cell	NULL
viability	NULL
)	NULL
and	NULL
polybrene	NULL
.	NULL

After	NULL
20-22	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
were	NULL
plated	NULL
in	NULL
methylcellulose	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
G-CSF	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
the	NULL
same	NULL
culture	NULL
conditions	NULL
without	NULL
polybrene	NULL
for	NULL
an	NULL
additional	NULL
4	NULL
d	NULL
and	NULL
stained	NULL
with	NULL
biotinylated	NULL
G-CSF	NULL
to	NULL
demonstrate	NULL
induction	NULL
of	NULL
high	NULL
levels	NULL
of	NULL
G-CSF	NULL
receptor	NULL
by	NULL
the	NULL
retrovirus	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Colony	NULL
numbers	NULL
from	NULL
C/EBPa	NULL
heterozygous	NULL
mice	NULL
were	NULL
not	NULL
significantly	NULL
different	NULL
with	NULL
or	NULL
without	NULL
G-CSF	NULL
receptor	NULL
retrovirus	NULL
infection	NULL
.	NULL

No	NULL
colonies	NULL
were	NULL
observed	NULL
in	NULL
cultures	NULL
from	NULL
C/EBPa	NULL
«	NULL
~'-	NULL
mice	NULL
without	NULL
retrovirus	NULL
infection	NULL
,	NULL
or	NULL
with	NULL
retrovirus	NULL
infection	NULL
but	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
added	NULL
G-CSF	NULL
.	NULL

Infected	NULL
cells	NULL
from	NULL
C/	NULL
EBPa	NULL
heterozygous	NULL
mice	NULL
also	NULL
yielded	NULL
no	NULL
colonies	NULL
when	NULL
cultured	NULL
without	NULL
G-CSF	NULL
.	NULL

Colonies	NULL
were	NULL
observed	NULL
from	NULL
G-CSF	NULL
receptor	NULL
retrovirus-infected	NULL
C/EBPa~'-	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
G-CSF	NULL
,	NULL
but	NULL
less	NULL
than	NULL
the	NULL
number	NULL
from	NULL
C/	NULL
EBPa	NULL
heterozygous	NULL
hematopoietic	NULL
cells	NULL
after	NULL
retrovirus	NULL
infection	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Mature	NULL
granulocytes	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
-/	NULL
-	NULL
colonies	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
F	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
when	NULL
infected	NULL
cells	NULL
were	NULL
plated	NULL
in	NULL
medium	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-6	NULL
and	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
in	NULL
addition	NULL
to	NULL
G-CSF	NULL
,	NULL
the	NULL
colony	NULL
numbers	NULL
were	NULL
only	NULL
slightly	NULL
increased	NULL
,	NULL
but	NULL
the	NULL
percentage	NULL
of	NULL
mature	NULL
granulocytes	NULL
from	NULL
C/EBPa~'-	NULL
cells	NULL
was	NULL
increased	NULL
to	NULL
almost	NULL
the	NULL
same	NULL
level	NULL
as	NULL
that	NULL
from	NULL
C/EBPa	NULL
heterozygous	NULL
mice	NULL
(	NULL
Tables	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
restoration	NULL
of	NULL
both	NULL
IL-6	NULL
receptor	NULL
and	NULL
G-CSF	NULL
receptor	NULL
levels	NULL
restored	NULL
granulocyte	NULL
production	NULL
in	NULL
vitro	NULL
.	NULL

Discussion	NULL
Previously	NULL
,	NULL
we	NULL
had	NULL
reported	NULL
that	NULL
granulocyte	NULL
differentiation	NULL
and	NULL
maturation	NULL
were	NULL
selectively	NULL
blocked	NULL
,	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
G-CSF	NULL
receptor	NULL
mRNA	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
in	NULL
cells	NULL
from	NULL
mice	NULL
with	NULL
a	NULL
targeted	NULL
disruption	NULL
of	NULL
the	NULL
C/EBPa	NULL
gene	NULL
.	NULL

However	NULL
,	NULL
mice	NULL
with	NULL
a	NULL
targeted	NULL
disruption	NULL
of	NULL
either	NULL
G-CSF	NULL
(	NULL
37	NULL
)	NULL
or	NULL
G-CSF	NULL
receptor	NULL
(	NULL
19	NULL
)	NULL
show	NULL
a	NULL
decrease	NULL
only	NULL
in	NULL
the	NULL
number	NULL
of	NULL
peripheral	NULL
C/EBPo	NULL
+/-	NULL
C/EBPo	NULL
-/	NULL
20	NULL
%	NULL
n	NULL
A0	NULL
800	NULL
1	NULL
%	NULL
i	NULL
i	NULL
1	NULL
1	NULL
,	NULL
22	NULL
09	NULL
m	NULL
10	NULL
10	NULL
1C	NULL
10	NULL
20	NULL
40	NULL
60	NULL
80	NULL
ioc	NULL
i	NULL
1	NULL
i	NULL
i	NULL
0	NULL
**	NULL
rg	NULL
+	NULL
r	NULL
u	NULL
1¢	NULL
“	NULL
II1	NULL
1	NULL
&	NULL
2	NULL
10	NULL
1180	NULL
L	NULL
Without	NULL
RV	NULL
infection	NULL
With	NULL
RV	NULL
infection	NULL
blood	NULL
neutrophils	NULL
but	NULL
are	NULL
not	NULL
blocked	NULL
in	NULL
maturation	NULL
.	NULL

Therefore	NULL
,	NULL
other	NULL
mechanisms	NULL
in	NULL
addition	NULL
to	NULL
G-CSF	NULL
are	NULL
involved	NULL
for	NULL
induction	NULL
of	NULL
granulopoiesis	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
show	NULL
that	NULL
hematopoietic	NULL
cells	NULL
from	NULL
C/EBPa	NULL
«	NULL
~	NULL
'	NULL
~-	NULL
fetal	NULL
liver	NULL
can	NULL
form	NULL
CFU-GM	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-3	NULL
or	NULL
GM-CSF	NULL
in	NULL
vitro	NULL
.	NULL

However	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
mature	NULL
granulocytes	NULL
is	NULL
lower	NULL
in	NULL
-/	NULL
-	NULL
than	NULL
in	NULL
wild-type	NULL
cells	NULL
These	NULL
results	NULL
indicate	NULL
that	NULL
immature	NULL
myeloid	NULL
progenitors	NULL
are	NULL
present	NULL
in	NULL
C/	NULL
EBPa	NULL
«	NULL
-~	NULL
'	NULL
-	NULL
mice	NULL
,	NULL
and	NULL
those	NULL
progenitors	NULL
respond	NULL
to	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
.	NULL

Interestingly	NULL
,	NULL
these	NULL
cells	NULL
do	NULL
not	NULL
mature	NULL
in	NULL
response	NULL
to	NULL
retinoic	NULL
acid	NULL
,	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
granulocytic	NULL
differentiation	NULL
(	NULL
38	NULL
)	NULL
,	NULL
given	NULL
both	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
immature	NULL
cells	NULL
also	NULL
do	NULL
not	NULL
respond	NULL
to	NULL
IL-6	NULL
and	NULL
G-CSF	NULL
in	NULL
vitro	NULL
.	NULL

There	NULL
are	NULL
several	NULL
possible	NULL
explanations	NULL
for	NULL
why	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
could	NULL
stimulate	NULL
myeloid	NULL
precursors	NULL
to	NULL
differentiate	NULL
into	NULL
mature	NULL
granulocytes	NULL
in	NULL
vitro	NULL
,	NULL
but	NULL
granulocytes	NULL
are	NULL
not	NULL
observed	NULL
in	NULL
vivo	NULL
.	NULL

First	NULL
,	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
are	NULL
not	NULL
normally	NULL
produced	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
,	NULL
but	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
and	NULL
mast	NULL
cells	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Fetal	NULL
T	NULL
cells	NULL
and	NULL
mast	NULL
cells	NULL
are	NULL
not	NULL
normally	NULL
activated	NULL
by	NULL
pathogens	NULL
because	NULL
of	NULL
the	NULL
protection	NULL
of	NULL
the	NULL
placental	NULL
barrier	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
hypothesis	NULL
,	NULL
neither	NULL
GM-CSF	NULL
nor	NULL
IL-3	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
adult	NULL
bone	NULL
marrow	NULL
,	NULL
during	NULL
embryonic	NULL
stem	NULL
cell	NULL
differentiation	NULL
by	NULL
RT-PCR	NULL
or	NULL
during	NULL
in	NULL
vitro	NULL
culture	NULL
of	NULL
embryonic	NULL
blastocysts	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
fetus	NULL
does	NULL
not	NULL
produce	NULL
its	NULL
own	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
IL-3	NULL
could	NULL
rescue	NULL
granulopoiesis	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
administered	NULL
IL-3	NULL
into	NULL
a	NULL
C/	NULL
EBPa*'~	NULL
pregnant	NULL
female	NULL
that	NULL
had	NULL
mated	NULL
with	NULL
a	NULL
C/	NULL
EBPa*'~	NULL
male	NULL
.	NULL

Day	NULL
19	NULL
embryos	NULL
were	NULL
analyzed	NULL
,	NULL
but	NULL
no	NULL
mature	NULL
granulocytes	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
C/	NULL
EBPa~'~-	NULL
peripheral	NULL
blood	NULL
or	NULL
fetal	NULL
liver	NULL
.	NULL

However	NULL
,	NULL
since	NULL
no	NULL
changes	NULL
were	NULL
detected	NULL
in	NULL
C/EBPa	NULL
wild-type	NULL
fetuses	NULL
as	NULL
well	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
may	NULL
,	NULL
like	NULL
erythropoietin	NULL
(	NULL
42	NULL
)	NULL
but	NULL
not	NULL
G-CSF	NULL
(	NULL
43	NULL
)	NULL
,	NULL
be	NULL
unable	NULL
to	NULL
cross	NULL
the	NULL
placental	NULL
barrier	NULL
.	NULL

Mice	NULL
deficient	NULL
in	NULL
the	NULL
entire	NULL
IL-3/GM-CSF/IL-5	NULL
signaling	NULL
pathway	NULL
revealed	NULL
normal	NULL
numbers	NULL
of	NULL
total	NULL
peripheral	NULL
leukocyte	NULL
counts	NULL
and	NULL
differential	NULL
counts	NULL
except	NULL
for	NULL
eosinophils	NULL
(	NULL
44	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
are	NULL
not	NULL
necessary	NULL
for	NULL
Figure	NULL
5	NULL
.	NULL

-	NULL
Transduction	NULL
of	NULL
G-CSF	NULL
receptor	NULL
using	NULL
retroviral	NULL
infection	NULL
of	NULL
C/	NULL
EBPa~'~	NULL
fetal	NULL
liver	NULL
cells	NULL
The	NULL
histograms	NULL
represent	NULL
analysis	NULL
of	NULL
surface	NULL
expression	NULL
of	NULL
G-CSF	NULL
receptors	NULL
on	NULL
cells	NULL
from	NULL
C/	NULL
EBPa	NULL
heterozygous	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
and	NULL
C/	NULL
EBPa~~	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
without	NULL
(	NULL
A	NULL
and	NULL
C	NULL
)	NULL
or	NULL
after	NULL
(	NULL
B	NULL
and	NULL
D	NULL
)	NULL
infection	NULL
with	NULL
a	NULL
murine	NULL
G-CSF	NULL
receptor	NULL
expressing	NULL
retrovirus	NULL
,	NULL
followed	NULL
by	NULL
culture	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SCF	NULL
only	NULL
for	NULL
5	NULL
d	NULL
,	NULL
then	NULL
FACS®	NULL
analysis	NULL
after	NULL
staining	NULL
with	NULL
biotinylated	NULL
G-CSF	NULL
.	NULL

b	NULL
and	NULL
bar	NULL
,	NULL
Profiles	NULL
obtained	NULL
with	NULL
biotinylated	NULL
and	NULL
unbiotinylated	NULL
G-CSF	NULL
,	NULL
respec-tively	NULL
.	NULL

y-axis	NULL
,	NULL
Number	NULL
of	NULL
events	NULL
(	NULL
10,000	NULL
events	NULL
counted	NULL
in	NULL
each	NULL
panel	NULL
)	NULL
;	NULL
x-axis	NULL
,	NULL
lOg1q	NULL
fluorescence	NULL
.	NULL

RV	NULL
,	NULL
R	NULL
etrovirus	NULL
.	NULL

IL-6	NULL
and	NULL
G-CSF	NULL
Receptors	NULL
in	NULL
Granulopoiesis	NULL
routine	NULL
production	NULL
of	NULL
mature	NULL
neutrophils	NULL
.	NULL

These	NULL
two	NULL
factors	NULL
may	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
expansion	NULL
of	NULL
hematopoietic	NULL
cells	NULL
in	NULL
emergency	NULL
situations	NULL
(	NULL
39	NULL
)	NULL
.	NULL

IL-3	NULL
and	NULL
GM-CSF	NULL
share	NULL
a	NULL
common	NULL
B	NULL
chain	NULL
receptor	NULL
which	NULL
signals	NULL
by	NULL
inducing	NULL
protein	NULL
phosphorylation	NULL
of	NULL
similar	NULL
proteins	NULL
(	NULL
45	NULL
)	NULL
;	NULL
the	NULL
two	NULL
cytokines	NULL
can	NULL
also	NULL
compete	NULL
with	NULL
each	NULL
other	NULL
in	NULL
binding	NULL
to	NULL
their	NULL
high-affinity	NULL
receptors	NULL
(	NULL
46	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
studies	NULL
suggest	NULL
that	NULL
there	NULL
may	NULL
be	NULL
a	NULL
cell	NULL
population	NULL
in	NULL
mice	NULL
that	NULL
expresses	NULL
both	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
receptors	NULL
on	NULL
the	NULL
cell	NULL
sur-face	NULL
.	NULL

This	NULL
population	NULL
apparently	NULL
exists	NULL
in	NULL
the	NULL
C/	NULL
EBPa-'~	NULL
mice	NULL
,	NULL
but	NULL
because	NULL
there	NULL
is	NULL
no	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
in	NULL
the	NULL
fe-tus	NULL
,	NULL
this	NULL
population	NULL
might	NULL
not	NULL
differentiate	NULL
in	NULL
vivo	NULL
but	NULL
could	NULL
nevertheless	NULL
differentiate	NULL
in	NULL
vitro	NULL
after	NULL
stimulation	NULL
with	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
G-CSF	NULL
signaling	NULL
alone	NULL
could	NULL
not	NULL
explain	NULL
the	NULL
phenotype	NULL
of	NULL
C/	NULL
EBPa-deficient	NULL
mice	NULL
,	NULL
and	NULL
IL-6	NULL
is	NULL
another	NULL
important	NULL
growth	NULL
factor	NULL
for	NULL
myeloid	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
(	NULL
20-22	NULL
)	NULL
.	NULL

Our	NULL
previous	NULL
studies	NULL
suggested	NULL
that	NULL
G-CSF	NULL
receptor	NULL
and	NULL
IL-6	NULL
receptor	NULL
stimulated	NULL
the	NULL
same	NULL
myeloid	NULL
progenitors	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
G-CSF	NULL
receptor	NULL
,	NULL
the	NULL
IL-6	NULL
receptor	NULL
could	NULL
be	NULL
a	NULL
candidate	NULL
target	NULL
for	NULL
the	NULL
C/EBPa	NULL
transcription	NULL
factor	NULL
,	NULL
and	NULL
in-deed	NULL
,	NULL
the	NULL
number	NULL
of	NULL
CFU-IL6	NULL
is	NULL
drastically	NULL
reduced	NULL
in	NULL
C/EBPa	NULL
«	NULL
~'-	NULL
mice	NULL
.	NULL

The	NULL
phenotype	NULL
of	NULL
mice	NULL
deficient	NULL
in	NULL
the	NULL
IL-6	NULL
signal	NULL
transducer	NULL
gp130	NULL
is	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
C/EBPa	NULL
«	NULL
-~'-	NULL
mice	NULL
(	NULL
47	NULL
)	NULL
,	NULL
so	NULL
we	NULL
focused	NULL
our	NULL
studies	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-6	NULL
receptor	NULL
.	NULL

Like	NULL
G-CSF	NULL
receptor	NULL
,	NULL
IL-6	NULL
receptor	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
total	NULL
fetal	NULL
liver	NULL
RNA	NULL
from	NULL
C/EBPa~'~	NULL
mice	NULL
.	NULL

By	NULL
quantitative	NULL
RT-PCR	NULL
,	NULL
IL-6	NULL
receptor	NULL
could	NULL
be	NULL
detected	NULL
,	NULL
but	NULL
IL-6	NULL
receptor	NULL
mRNA	NULL
in	NULL
C/EBPa	NULL
«	NULL
~'-	NULL
mice	NULL
is	NULL
170-fold	NULL
lower	NULL
than	NULL
in	NULL
wild-type	NULL
mice	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
gp130	NULL
is	NULL
normal	NULL
in	NULL
C/EBPa~'~	NULL
compared	NULL
with	NULL
wild-type	NULL
mice	NULL
.	NULL

Staining	NULL
of	NULL
hematopoietic	NULL
cells	NULL
from	NULL
C/	NULL
EBPa	NULL
wild-type	NULL
and	NULL
-/	NULL
-	NULL
fetal	NULL
liver	NULL
with	NULL
biotinylated	NULL
G-CSF	NULL
and	NULL
IL-6	NULL
demonstrated	NULL
no	NULL
surface	NULL
G-CSF	NULL
receptor	NULL
and	NULL
IL-6	NULL
receptor-positive	NULL
cell	NULL
populations	NULL
in	NULL
C/EBPa-'-	NULL
mice	NULL
.	NULL

When	NULL
C/EBPa-~	NULL
'	NULL
-	NULL
cells	NULL
were	NULL
induced	NULL
to	NULL
differentiate	NULL
to	NULL
mature	NULL
granulocytes	NULL
with	NULL
IL-3	NULL
and	NULL
SCF	NULL
or	NULL
GM-CSF	NULL
and	NULL
SCF	NULL
,	NULL
the	NULL
morphologically	NULL
mature	NULL
cells	NULL
are	NULL
still	NULL
IL-6	NULL
and	NULL
G-CSF	NULL
re-ceptor-negative	NULL
.	NULL

These	NULL
findings	NULL
demonstrate	NULL
that	NULL
C/	NULL
EBPa	NULL
is	NULL
a	NULL
major	NULL
regulator	NULL
for	NULL
both	NULL
IL-6	NULL
receptor	NULL
and	NULL
G-CSF	NULL
receptor	NULL
in	NULL
vivo	NULL
,	NULL
and	NULL
mature	NULL
cells	NULL
from	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
stimulation	NULL
in	NULL
vitro	NULL
do	NULL
not	NULL
express	NULL
IL-6	NULL
and	NULL
G-CSF	NULL
receptors	NULL
.	NULL

The	NULL
proliferation	NULL
and	NULL
survival	NULL
of	NULL
these	NULL
cells	NULL
depend	NULL
on	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
but	NULL
not	NULL
IL-6	NULL
and	NULL
G-CSF	NULL
.	NULL

Mice	NULL
with	NULL
a	NULL
disruption	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
fail	NULL
to	NULL
efficiently	NULL
control	NULL
infection	NULL
with	NULL
vaccinia	NULL
virus	NULL
and	NULL
Listeria	NULL
monocytogenes	NULL
,	NULL
a	NULL
faculta-tive	NULL
intracellular	NULL
bacterium	NULL
,	NULL
and	NULL
in	NULL
these	NULL
animals	NULL
the	NULL
inflammatory	NULL
acute-phase	NULL
response	NULL
after	NULL
tissue	NULL
damage	NULL
or	NULL
infection	NULL
is	NULL
severely	NULL
compromised	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
report	NULL
and	NULL
our	NULL
current	NULL
findings	NULL
is	NULL
the	NULL
additional	NULL
observation	NULL
that	NULL
the	NULL
acute-phase	NULL
response	NULL
is	NULL
completely	NULL
lacking	NULL
in	NULL
these	NULL
same	NULL
C/	NULL
EBPa	NULL
«	NULL
~'~	NULL
mice	NULL
(	NULL
Burgess	NULL
Beusse	NULL
,	NULL
B.L	NULL
.	NULL

,	NULL
and	NULL
G.J	NULL
.	NULL

Darlington	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
,	NULL
perhaps	NULL
due	NULL
in	NULL
part	NULL
to	NULL
the	NULL
loss	NULL
of	NULL
IL-6	NULL
receptor	NULL
expression	NULL
.	NULL

Because	NULL
hematopoietic	NULL
cells	NULL
from	NULL
C/	NULL
EBP	NULL
«	NULL
-~'~	NULL
mice	NULL
lack	NULL
normal	NULL
numbers	NULL
of	NULL
IL-6	NULL
receptors	NULL
,	NULL
no	NULL
colonies	NULL
were	NULL
ob	NULL
1181	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

served	NULL
in	NULL
CFU	NULL
assays	NULL
from	NULL
C/EBPa	NULL
«	NULL
~	NULL
'	NULL
-	NULL
cells	NULL
when	NULL
stimulated	NULL
with	NULL
IL-6	NULL
only	NULL
.	NULL

IL-6	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
soluble	NULL
form	NULL
of	NULL
the	NULL
IL-6	NULL
receptor	NULL
,	NULL
and	NULL
can	NULL
trigger	NULL
gp130	NULL
signaling	NULL
on	NULL
target	NULL
cells	NULL
lacking	NULL
the	NULL
IL-6	NULL
receptor	NULL
but	NULL
expressing	NULL
gp	NULL
130	NULL
.	NULL

When	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
and	NULL
IL-6	NULL
were	NULL
added	NULL
to	NULL
C/	NULL
EBPa-~	NULL
'	NULL
~	NULL
cells	NULL
,	NULL
CFU	NULL
were	NULL
observed	NULL
at	NULL
a	NULL
level	NULL
30	NULL
%	NULL
that	NULL
of	NULL
wild-type	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
G-CSF	NULL
to	NULL
the	NULL
cultures	NULL
with	NULL
IL-6	NULL
and	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
resulted	NULL
in	NULL
increased	NULL
numbers	NULL
of	NULL
colonies	NULL
and	NULL
percentage	NULL
of	NULL
mature	NULL
granulocytes	NULL
in	NULL
the	NULL
colonies	NULL
.	NULL

Previously	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
IL-6	NULL
stimulates	NULL
stem	NULL
cells	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
respond	NULL
to	NULL
IL-3	NULL
,	NULL
and	NULL
when	NULL
IL-6	NULL
is	NULL
combined	NULL
with	NULL
other	NULL
recombinant	NULL
hematopoietic	NULL
factors	NULL
,	NULL
including	NULL
G-CSF	NULL
,	NULL
it	NULL
can	NULL
augment	NULL
responses	NULL
to	NULL
these	NULL
factors	NULL
or	NULL
even	NULL
modify	NULL
them	NULL
(	NULL
49	NULL
)	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
here	NULL
suggest	NULL
that	NULL
G-CSF	NULL
signaling	NULL
may	NULL
be	NULL
one	NULL
of	NULL
the	NULL
growth	NULL
factor	NULL
pathways	NULL
whose	NULL
function	NULL
can	NULL
be	NULL
augmented	NULL
by	NULL
IL-6	NULL
.	NULL

The	NULL
block	NULL
of	NULL
granulocytic	NULL
differentiation	NULL
in	NULL
C/	NULL
EBPa	NULL
«	NULL
_~'~	NULL
mice	NULL
can	NULL
only	NULL
be	NULL
partially	NULL
rescued	NULL
in	NULL
vitro	NULL
by	NULL
restoration	NULL
of	NULL
IL-6	NULL
receptor	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
infected	NULL
fetal	NULL
liver	NULL
cells	NULL
from	NULL
C/EBPa	NULL
wild-type	NULL
and	NULL
-/-	NULL
mice	NULL
with	NULL
a	NULL
retrovirus	NULL
expressing	NULL
the	NULL
wild-type	NULL
G-CSF	NULL
receptor	NULL
.	NULL

When	NULL
the	NULL
cells	NULL
were	NULL
placed	NULL
in	NULL
culture	NULL
without	NULL
added	NULL
growth	NULL
factors	NULL
,	NULL
no	NULL
colonies	NULL
were	NULL
detected	NULL
after	NULL
retrovirus	NULL
infection	NULL
from	NULL
both	NULL
wild-type	NULL
and	NULL
-/	NULL
-	NULL
mice	NULL
.	NULL

When	NULL
infected	NULL
cells	NULL
from	NULL
the	NULL
C/	NULL
EBPa-~'-	NULL
mice	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
G-CSF	NULL
,	NULL
cells	NULL
from	NULL
-/	NULL
-	NULL
liver	NULL
generated	NULL
half	NULL
the	NULL
number	NULL
of	NULL
colonies	NULL
compared	NULL
with	NULL
wild-type	NULL
liver	NULL
,	NULL
and	NULL
these	NULL
colonies	NULL
contained	NULL
mature	NULL
granulocytes	NULL
in	NULL
addition	NULL
to	NULL
macrophages	NULL
and	NULL
immature	NULL
myeloid	NULL
cells	NULL
.	NULL

With	NULL
the	NULL
addition	NULL
of	NULL
IL-6	NULL
and	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
to	NULL
the	NULL
same	NULL
cultures	NULL
,	NULL
the	NULL
colony	NULL
number	NULL
was	NULL
still	NULL
lower	NULL
than	NULL
in	NULL
wild-type	NULL
.	NULL

Furthermore	NULL
,	NULL
our	NULL
recent	NULL
A	NULL
CFU-G	NULL
CFU-ILé	NULL
O-	NULL
©	NULL
C/EBPo	NULL
?	NULL

/	NULL
©	NULL
©	NULL
Granulocyte	NULL
Stem	NULL
Cell	NULL
Multipotent	NULL
>	NULL
>	NULL
Myeloid	NULL
©	NULL
--	NULL
»	NULL
Progenitor	NULL
CFU-IL3	NULL
CFU-GM	NULL
B	NULL
?	NULL

?	NULL

C/EBPa	NULL
<	NULL
2	NULL
O	NULL
--	NULL
CO	NULL
--	NULL
C	NULL
-	NULL
©	NULL
Multipotent	NULL
-	NULL
pry.fp3	NULL
CFU-G	NULL
locyt	NULL
Stem	NULL
Cell	NULL
Myeloid	NULL
CFU-GM	NULL
CFUILé	NULL
Granulocyte	NULL
Progenitor	NULL
Figure	NULL
6	NULL
.	NULL

_	NULL
Two	NULL
models	NULL
of	NULL
granulocytic	NULL
development	NULL
.	NULL

(	NULL
A	NULL
)	NULL
A	NULL
pluripoten-tial	NULL
stem	NULL
cell	NULL
differentiates	NULL
into	NULL
an	NULL
immature	NULL
multipotent	NULL
myeloid	NULL
progen-itor	NULL
,	NULL
perhaps	NULL
under	NULL
the	NULL
influence	NULL
of	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
PU.1	NULL
(	NULL
reference	NULL
2	NULL
)	NULL
.	NULL

This	NULL
cell	NULL
can	NULL
then	NULL
further	NULL
differentiate	NULL
to	NULL
a	NULL
mature	NULL
granulo-cyte	NULL
,	NULL
either	NULL
via	NULL
a	NULL
CFU-G/	NULL
CFU-IL6	NULL
precursor	NULL
which	NULL
is	NULL
dependent	NULL
upon	NULL
C/EBPa	NULL
function	NULL
,	NULL
or	NULL
via	NULL
a	NULL
CFU-IL3/CFU-GM	NULL
precursor	NULL
which	NULL
is	NULL
C/	NULL
EBPa	NULL
independent	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
multipotent	NULL
progenitor	NULL
differentiates	NULL
into	NULL
an	NULL
early	NULL
granulocytic	NULL
precursor	NULL
that	NULL
can	NULL
respond	NULL
to	NULL
IL-3	NULL
and/or	NULL
GM-CSF	NULL
,	NULL
which	NULL
itself	NULL
is	NULL
induced	NULL
to	NULL
differentiate	NULL
further	NULL
under	NULL
the	NULL
influence	NULL
of	NULL
C/	NULL
EBPa	NULL
to	NULL
a	NULL
precursor	NULL
that	NULL
responds	NULL
to	NULL
G-CSF	NULL
and/	NULL
or	NULL
IL-6	NULL
.	NULL

studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
IL-6	NULL
and	NULL
G-CSF	NULL
receptor	NULL
double	NULL
knockout	NULL
phenotype	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
G-CSF	NULL
receptor	NULL
alone	NULL
and	NULL
,	NULL
unlike	NULL
the	NULL
C/EBP	NULL
«	NULL
~'-	NULL
mouse	NULL
,	NULL
still	NULL
makes	NULL
mature	NULL
granulocytes	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
IL-6	NULL
and	NULL
G-CSF	NULL
receptor	NULL
,	NULL
some	NULL
other	NULL
genes	NULL
are	NULL
affected	NULL
in	NULL
the	NULL
C/	NULL
EBPa~	NULL
'	NULL
~	NULL
mice	NULL
(	NULL
15a	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
G-CSF	NULL
receptor	NULL
and	NULL
gp130	NULL
have	NULL
a	NULL
similar	NULL
intracellular	NULL
domain	NULL
and	NULL
activate	NULL
similar	NULL
signaling	NULL
pathways	NULL
,	NULL
our	NULL
combined	NULL
data	NULL
suggest	NULL
that	NULL
there	NULL
is	NULL
a	NULL
G-CSF	NULL
and	NULL
IL-6	NULL
receptor-positive	NULL
cell	NULL
population	NULL
in	NULL
mice	NULL
.	NULL

The	NULL
generation	NULL
of	NULL
mature	NULL
granulocytes	NULL
from	NULL
this	NULL
population	NULL
of	NULL
cells	NULL
is	NULL
blocked	NULL
due	NULL
to	NULL
the	NULL
lack	NULL
of	NULL
IL-6	NULL
and	NULL
G-CSF	NULL
responsiveness	NULL
,	NULL
but	NULL
another	NULL
population	NULL
can	NULL
respond	NULL
,	NULL
at	NULL
least	NULL
in	NULL
vitro	NULL
,	NULL
to	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
.	NULL

Whether	NULL
such	NULL
a	NULL
population	NULL
exists	NULL
in	NULL
vivo	NULL
can	NULL
potentially	NULL
be	NULL
addressed	NULL
once	NULL
mice	NULL
with	NULL
selective	NULL
restoration	NULL
of	NULL
C/	NULL
EBPa	NULL
expression	NULL
in	NULL
liver	NULL
and	NULL
not	NULL
blood	NULL
,	NULL
and	NULL
with	NULL
longer	NULL
viability	NULL
,	NULL
are	NULL
produced	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
C/	NULL
EBPa	NULL
may	NULL
directly	NULL
or	NULL
indirectly	NULL
regulate	NULL
the	NULL
IL-6	NULL
receptor	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
C/EBPa	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
marked	NULL
decrease	NULL
in	NULL
IL-6	NULL
and	NULL
G-CSF	NULL
receptor	NULL
expression	NULL
.	NULL

Neither	NULL
IL-6	NULL
nor	NULL
G-CSF	NULL
signaling	NULL
is	NULL
required	NULL
for	NULL
myeloid	NULL
cell	NULL
lineage	NULL
commitment	NULL
,	NULL
but	NULL
they	NULL
are	NULL
likely	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
proliferation	NULL
and/	NULL
or	NULL
viability	NULL
of	NULL
myeloid	NULL
precursors	NULL
.	NULL

O	NULL
ur	NULL
results	NULL
raise	NULL
the	NULL
very	NULL
interesting	NULL
possibility	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
that	NULL
two	NULL
distinct	NULL
populations	NULL
of	NULL
granulocyte-	NULL
macrophage	NULL
progenitors	NULL
are	NULL
present	NULL
in	NULL
the	NULL
murine	NULL
hematopoietic	NULL
system	NULL
,	NULL
one	NULL
G-CSF	NULL
and	NULL
IL-6	NULL
dependent	NULL
and	NULL
the	NULL
other	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
dependent	NULL
.	NULL

Alternatively	NULL
,	NULL
granulocyte	NULL
development	NULL
occurs	NULL
in	NULL
several	NULL
stages	NULL
,	NULL
beginning	NULL
with	NULL
an	NULL
IL-3	NULL
and	NULL
GM-CSF-responsive	NULL
precursor	NULL
,	NULL
which	NULL
itself	NULL
can	NULL
further	NULL
differentiate	NULL
to	NULL
become	NULL
responsive	NULL
to	NULL
G-CSF	NULL
and	NULL
IL-6	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
.	NULL

This	NULL
latter	NULL
model	NULL
is	NULL
more	NULL
consistent	NULL
with	NULL
the	NULL
hierarchical	NULL
expression	NULL
of	NULL
CSF	NULL
receptors	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
tend	NULL
to	NULL
support	NULL
the	NULL
first	NULL
model	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
.	NULL

At	NULL
least	NULL
in	NULL
vitro	NULL
,	NULL
loss	NULL
of	NULL
C/	NULL
EBPa	NULL
mainly	NULL
affects	NULL
the	NULL
G-CSF/IL-6-dependent	NULL
precursor	NULL
,	NULL
and	NULL
stimulation	NULL
of	NULL
either	NULL
IL-3	NULL
or	NULL
GM-CSF	NULL
can	NULL
induce	NULL
granulocyte	NULL
formation	NULL
.	NULL

If	NULL
such	NULL
a	NULL
model	NULL
is	NULL
correct	NULL
,	NULL
it	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
why	NULL
this	NULL
latter	NULL
pathway	NULL
is	NULL
incapable	NULL
of	NULL
inducing	NULL
formation	NULL
of	NULL
mature	NULL
granulocytes	NULL
in	NULL
C/	NULL
EBPa	NULL
«	NULL
knockout	NULL
animals	NULL
.	NULL

We	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
Tetsuya	NULL
Taga	NULL
for	NULL
his	NULL
generous	NULL
gift	NULL
of	NULL
IL-6	NULL
,	NULL
soluble	NULL
IL-6	NULL
receptor	NULL
,	NULL
and	NULL
the	NULL
IL-6	NULL
receptor	NULL
cDNA	NULL
;	NULL
Connie	NULL
Eaves	NULL
for	NULL
providing	NULL
murine	NULL
IL-3	NULL
;	NULL
Jose-Carlos	NULL
Gutierrez-R	NULL
amos	NULL
for	NULL
the	NULL
pSPCR	NULL
1	NULL
plasmid	NULL
used	NULL
for	NULL
quantitative	NULL
PCR	NULL
analysis	NULL
of	NULL
IL-6	NULL
receptor	NULL
and	NULL
G-CSF	NULL
receptor	NULL
expression	NULL
;	NULL
and	NULL
Bruce	NULL
Tor-bett	NULL
,	NULL
Hanna	NULL
R	NULL
adomska	NULL
,	NULL
and	NULL
Hui-min	NULL
Chen	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
comments	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
HL-56745	NULL
and	NULL
CA-72009	NULL
)	NULL
to	NULL
D.G	NULL
.	NULL

Tenen	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Daniel	NULL
G.	NULL
Tenen	NULL
,	NULL
Harvard	NULL
Institutes	NULL
of	NULL
Medicine	NULL
,	NULL
Rm	NULL
.	NULL

954	NULL
,	NULL
77	NULL
Ave.	NULL
Louis	NULL
Pas	NULL
teur	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

Phone	NULL
:	NULL
617-667-5561	NULL
;	NULL
Fax	NULL
:	NULL
617-667-3299	NULL
;	NULL
E-mail	NULL
:	NULL
dtenen	NULL
@	NULL
bidmc.harvard.edu	NULL
Received	NULL
for	NULL
publication	NULL
6	NULL
May	NULL
1998	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
29	NULL
June	NULL
1998	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Shivdasani	NULL
,	NULL
R.A.	NULL
,	NULL
and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
transcriptional	NULL
control	NULL
of	NULL
hematopoiesis	NULL
.	NULL

Blood	NULL
.	NULL

87:4025-4039	NULL
.	NULL

2	NULL
.	NULL

Tenen	NULL
,	NULL
D.G	NULL
.	NULL

,	NULL
R.	NULL
Hromas	NULL
,	NULL
J.D	NULL
.	NULL

Licht	NULL
,	NULL
and	NULL
D.-E.	NULL
Zhang	NULL
.	NULL

1997	NULL
.	NULL

Transcription	NULL
factors	NULL
,	NULL
normal	NULL
myeloid	NULL
development	NULL
,	NULL
and	NULL
leukemia	NULL
.	NULL

Blood	NULL
.	NULL

90:489-519	NULL
.	NULL

3	NULL
.	NULL

Zon	NULL
,	NULL
LL	NULL
.	NULL

,	NULL
H.	NULL
Youssoufian	NULL
,	NULL
C.	NULL
Mather	NULL
,	NULL
H.F.	NULL
Lodish	NULL
,	NULL
and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1991	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
promoter	NULL
by	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sd	NULL
.	NULL

USA	NULL
.	NULL

88:10638-10641	NULL
.	NULL

4	NULL
.	NULL

Zhang	NULL
,	NULL
D.-E.	NULL
,	NULL
C.J	NULL
.	NULL

Hetherington	NULL
,	NULL
H.M.	NULL
Chen	NULL
,	NULL
and	NULL
D.G	NULL
.	NULL

Tenen	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
macrophage	NULL
transcription	NULL
factor	NULL
PU.1	NULL
directs	NULL
tissue-specific	NULL
expression	NULL
of	NULL
the	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:373-381	NULL
.	NULL

5	NULL
.	NULL

Smith	NULL
,	NULL
LT.	NULL
,	NULL
S.	NULL
Hohaus	NULL
,	NULL
D.A	NULL
.	NULL

Gonzalez	NULL
,	NULL
S.E	NULL
.	NULL

Dziennis	NULL
,	NULL
and	NULL
D.G	NULL
.	NULL

Tenen	NULL
.	NULL

1996	NULL
.	NULL

PU.1	NULL
(	NULL
Spi-1	NULL
)	NULL
and	NULL
C/EBPa	NULL
regulate	NULL
the	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
promoter	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

Blood	NULL
88:1234-1247	NULL
.	NULL

6	NULL
.	NULL

Cao	NULL
,	NULL
Z.	NULL
,	NULL
R.M	NULL
.	NULL

Umek	NULL
,	NULL
and	NULL
S.L	NULL
.	NULL

McKnight	NULL
.	NULL

1991	NULL
.	NULL

Regulated	NULL
expression	NULL
of	NULL
three	NULL
C/EBP	NULL
isoforms	NULL
during	NULL
adipose	NULL
conversion	NULL
of	NULL
3T	NULL
3-L1	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:1538-1552	NULL
.	NULL

7	NULL
.	NULL

Screpanti	NULL
,	NULL
I.	NULL
,	NULL
L.	NULL
Romani	NULL
,	NULL
P.	NULL
Musiani	NULL
,	NULL
A.	NULL
Modesti	NULL
,	NULL
E.	NULL
Fattori	NULL
,	NULL
1182	NULL
D.	NULL
Lazzaro	NULL
,	NULL
C.	NULL
Sellitto	NULL
,	NULL
S.	NULL
Scarpa	NULL
,	NULL
D.	NULL
Bellavia	NULL
,	NULL
G.	NULL
Lattanzio	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
.	NULL

Lymphoproliferative	NULL
disorder	NULL
and	NULL
imbalanced	NULL
T-helper	NULL
response	NULL
in	NULL
C/	NULL
EBPB-deficient	NULL
mice	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

14:1932-1941	NULL
.	NULL

8	NULL
.	NULL

Tanaka	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
K.	NULL
Yoshida	NULL
,	NULL
M.	NULL
Umemoto	NULL
,	NULL
Y.	NULL
Yoneda	NULL
,	NULL
N.	NULL
Shirafuji	NULL
,	NULL
H.	NULL
Fujiwara	NULL
,	NULL
S.	NULL
Suematsu	NULL
,	NULL
N.	NULL
Yoshida	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1995	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
discloses	NULL
its	NULL
essential	NULL
role	NULL
in	NULL
bacteria	NULL
killing	NULL
and	NULL
tumor	NULL
cyto-toxicity	NULL
by	NULL
macrophages	NULL
.	NULL

Cell	NULL
.	NULL

80:353-361	NULL
.	NULL

9	NULL
.	NULL

Yamanaka	NULL
,	NULL
R.	NULL
,	NULL
C.	NULL
Barlow	NULL
,	NULL
J.	NULL
Lekstrom-Himes	NULL
,	NULL
LH	NULL
.	NULL

Castilia	NULL
,	NULL
P.P	NULL
.	NULL

Liu	NULL
,	NULL
M.	NULL
Eckhaus	NULL
,	NULL
T.	NULL
Decker	NULL
,	NULL
A.	NULL
Wynshaw-Boris	NULL
,	NULL
and	NULL
K.G	NULL
.	NULL

Xanthopoulos	NULL
.	NULL

1997	NULL
.	NULL

Impaired	NULL
granulopoiesis	NULL
,	NULL
myelo-dysplasia	NULL
and	NULL
early	NULL
lethality	NULL
in	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
e-deficient	NULL
mice	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aarid	NULL
Sd	NULL
.	NULL

USA	NULL
.	NULL

94	NULL
:	NULL
13187-13192	NULL
.	NULL

10	NULL
.	NULL

Christy	NULL
,	NULL
R.J.	NULL
,	NULL
V.W	NULL
.	NULL

Yang	NULL
,	NULL
J.M	NULL
.	NULL

Ntambi	NULL
,	NULL
D.E	NULL
.	NULL

Geiman	NULL
,	NULL
W.H	NULL
.	NULL

Landschulz	NULL
,	NULL
A.D.	NULL
Friedman	NULL
,	NULL
Y.	NULL
Nakabeppu	NULL
,	NULL
T.J.	NULL
Kelly	NULL
,	NULL
and	NULL
M.D	NULL
.	NULL

Lane	NULL
.	NULL

1989	NULL
.	NULL

Differentiation-induced	NULL
gene	NULL
expression	NULL
in	NULL
3T3-L1	NULL
preadipocytes	NULL
:	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
interacts	NULL
with	NULL
and	NULL
activates	NULL
the	NULL
promoters	NULL
of	NULL
two	NULL
adipocyte-specific	NULL
genes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1323-1335	NULL
.	NULL

IL-6	NULL
and	NULL
G-CSF	NULL
Receptors	NULL
in	NULL
Granulopoiesis	NULL
11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

Friedman	NULL
,	NULL
A.D.	NULL
,	NULL
W.H	NULL
.	NULL

Landschulz	NULL
,	NULL
and	NULL
S.L	NULL
.	NULL

McKnight	NULL
.	NULL

1989	NULL
.	NULL

CCAAT/enhancer	NULL
binding	NULL
protein	NULL
activates	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
serum	NULL
albumin	NULL
gene	NULL
in	NULL
cultured	NULL
hepatoma	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1314-1322	NULL
.	NULL

Wang	NULL
,	NULL
N.D.	NULL
,	NULL
M.J.	NULL
Finegold	NULL
,	NULL
A.	NULL
Bradley	NULL
,	NULL
C.N	NULL
.	NULL

Ou	NULL
,	NULL
S.V	NULL
.	NULL

Ab-delsayed	NULL
,	NULL
M.D	NULL
.	NULL

Wilde	NULL
,	NULL
LR	NULL
.	NULL

Taylor	NULL
,	NULL
D.R	NULL
.	NULL

Wilson	NULL
,	NULL
and	NULL
G.J	NULL
.	NULL

Darlington	NULL
.	NULL

1995	NULL
.	NULL

Impaired	NULL
energy	NULL
homeostasis	NULL
in	NULL
C/	NULL
EBPa	NULL
knockout	NULL
mice	NULL
.	NULL

Sdene	NULL
.	NULL

269:1108-1112	NULL
.	NULL

Flodby	NULL
,	NULL
P.	NULL
,	NULL
C.	NULL
Barlow	NULL
,	NULL
H.	NULL
Kylefjord	NULL
,	NULL
L.	NULL
Ahrlund-Richter	NULL
,	NULL
and	NULL
K.G	NULL
.	NULL

Xanthopoulos	NULL
.	NULL

1996	NULL
.	NULL

Increased	NULL
hepatic	NULL
cell	NULL
proliferation	NULL
and	NULL
lung	NULL
abnormalities	NULL
in	NULL
mice	NULL
deficient	NULL
in	NULL
CCAAT/	NULL
enhancer	NULL
binding	NULL
protein	NULL
a.	NULL
J	NULL
Biol	NULL
Chem	NULL
.	NULL

271:24753-24760	NULL
.	NULL

Scott	NULL
,	NULL
LM	NULL
.	NULL

,	NULL
C.I	NULL
.	NULL

Civin	NULL
,	NULL
P.	NULL
Rorth	NULL
,	NULL
and	NULL
A.D.	NULL
Friedman	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
temporal	NULL
expression	NULL
pattern	NULL
of	NULL
three	NULL
C/	NULL
EBP	NULL
family	NULL
members	NULL
in	NULL
differentiating	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

80	NULL
:	NULL
1725-1735	NULL
.	NULL

Ford	NULL
,	NULL
A.M.	NULL
,	NULL
C.A	NULL
.	NULL

Bennett	NULL
,	NULL
LE	NULL
.	NULL

Healy	NULL
,	NULL
M.	NULL
Towatari	NULL
,	NULL
M.F	NULL
.	NULL

Greaves	NULL
,	NULL
and	NULL
T.	NULL
Enver	NULL
.	NULL

1996	NULL
.	NULL

R	NULL
egulation	NULL
of	NULL
the	NULL
myeloperoxidase	NULL
enhancer	NULL
binding	NULL
proteins	NULL
PU.1	NULL
,	NULL
C-EBPa	NULL
,	NULL
B	NULL
,	NULL
and	NULL
8	NULL
during	NULL
granulocytic-lineage	NULL
specification	NULL
.	NULL

Proc	NULL
Natl	NULL
Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

93:10838-10843	NULL
.	NULL

15a.Iwama	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Zhang	NULL
,	NULL
G.J	NULL
.	NULL

Darlington	NULL
,	NULL
R.A.	NULL
Maki	NULL
,	NULL
and	NULL
D.G	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

Tenen	NULL
.	NULL

1998	NULL
.	NULL

Use	NULL
of	NULL
RDA	NULL
analysis	NULL
of	NULL
knockout	NULL
mice	NULL
to	NULL
identify	NULL
myeloid	NULL
genes	NULL
regulated	NULL
in	NULL
vivo	NULL
by	NULL
PU.1	NULL
and	NULL
C/EBPa	NULL
«	NULL
.	NULL

Nudeic	NULL
A	NULL
ads	NULL
Res	NULL
.	NULL

26:3034-3043	NULL
.	NULL

Oelgeschlager	NULL
,	NULL
M.	NULL
,	NULL
I.	NULL
Nuchprayoon	NULL
,	NULL
B.	NULL
Luscher	NULL
,	NULL
and	NULL
A.D.	NULL
Friedman	NULL
.	NULL

1996	NULL
.	NULL

C/	NULL
EBP	NULL
,	NULL
c-Myb	NULL
,	NULL
and	NULL
PU.1	NULL
cooperate	NULL
to	NULL
regulate	NULL
the	NULL
neutrophil	NULL
elastase	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
:	NULL
4717-4725	NULL
.	NULL

Radomska	NULL
,	NULL
H.S	NULL
.	NULL

,	NULL
C.S	NULL
.	NULL

Huettner	NULL
,	NULL
P.	NULL
Zhang	NULL
,	NULL
T.	NULL
Cheng	NULL
,	NULL
D.T	NULL
.	NULL

Scadden	NULL
,	NULL
and	NULL
D.G	NULL
.	NULL

Tenen	NULL
.	NULL

1998	NULL
.	NULL

CCAAT/	NULL
Enhancer	NULL
binding	NULL
protein	NULL
a	NULL
is	NULL
a	NULL
regulatory	NULL
switch	NULL
sufficient	NULL
for	NULL
induction	NULL
of	NULL
granulocytic	NULL
development	NULL
from	NULL
bipotential	NULL
myeloid	NULL
progenitors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:4301-4314	NULL
.	NULL

Zhang	NULL
,	NULL
D.-E.	NULL
,	NULL
P.	NULL
Zhang	NULL
,	NULL
N.D.	NULL
Wang	NULL
,	NULL
C.J	NULL
.	NULL

Hetherington	NULL
,	NULL
G.J	NULL
.	NULL

Darlington	NULL
,	NULL
and	NULL
D.G	NULL
.	NULL

Tenen	NULL
.	NULL

1997	NULL
.	NULL

Absence	NULL
of	NULL
granulocyte	NULL
stimulating	NULL
factor	NULL
signaling	NULL
and	NULL
neutrophil	NULL
development	NULL
in	NULL
CCAAT	NULL
enhancer	NULL
binding	NULL
protein	NULL
mice	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

94:569-574	NULL
.	NULL

Liu	NULL
,	NULL
F.	NULL
,	NULL
H.Y	NULL
.	NULL

Wu	NULL
,	NULL
R.L	NULL
Wesselschmidt	NULL
,	NULL
T.	NULL
Kornaga	NULL
,	NULL
and	NULL
D.C.	NULL
Link	NULL
.	NULL

1996	NULL
.	NULL

Impaired	NULL
production	NULL
and	NULL
increased	NULL
apopto-sis	NULL
of	NULL
neutrophils	NULL
in	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
receptor-deficient	NULL
mice	NULL
.	NULL

Immunity	NULL
.	NULL

5:491-501	NULL
.	NULL

Metcalf	NULL
,	NULL
D.	NULL
1991	NULL
.	NULL

Control	NULL
of	NULL
granulocytes	NULL
and	NULL
macrophages	NULL
:	NULL
molecular	NULL
,	NULL
cellular	NULL
,	NULL
and	NULL
clinical	NULL
aspects	NULL
.	NULL

Sdene	NULL
.	NULL

254:529-533	NULL
.	NULL

Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
M.	NULL
Narazaki	NULL
,	NULL
and	NULL
T.	NULL
Taga	NULL
.	NULL

1995	NULL
.	NULL

Interleukin-6	NULL
family	NULL
of	NULL
cytokines	NULL
and	NULL
gp130	NULL
.	NULL

Blood	NULL
.	NULL

86:1243-1254	NULL
.	NULL

Pojda	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
A.	NULL
Tsuboi	NULL
.	NULL

1990	NULL
.	NULL

In	NULL
vivo	NULL
effects	NULL
of	NULL
human	NULL
recombinant	NULL
interleukin	NULL
6	NULL
on	NULL
hemopoietic	NULL
stem	NULL
and	NULL
progenitor	NULL
cells	NULL
and	NULL
circulating	NULL
blood	NULL
cells	NULL
in	NULL
normal	NULL
mice	NULL
.	NULL

Exp	NULL
.	NULL

Hena	NULL
tol	NULL
.	NULL

18:1034-1037	NULL
.	NULL

Peters	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Schirmacher	NULL
,	NULL
J.	NULL
Goldschmitt	NULL
,	NULL
M.	NULL
Odenthal	NULL
,	NULL
C.	NULL
Peschel	NULL
,	NULL
E.	NULL
Fattori	NULL
,	NULL
G.	NULL
Ciliberto	NULL
,	NULL
H.P	NULL
.	NULL

Dienes	NULL
,	NULL
K.H	NULL
.	NULL

Meyer	NULL
zum	NULL
Buschenfelde	NULL
,	NULL
and	NULL
S.	NULL
Rose-John	NULL
.	NULL

1997	NULL
.	NULL

Extramedullary	NULL
expansion	NULL
of	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
in	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-6-sIL-6R	NULL
double	NULL
transgenic	NULL
mice	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
185	NULL
:	NULL
755-166	NULL
.	NULL

Suzuki	NULL
,	NULL
H.	NULL
,	NULL
A.	NULL
Okano	NULL
,	NULL
C.	NULL
Ejima	NULL
,	NULL
A.	NULL
Konishi	NULL
,	NULL
Y.	NULL
Akiyama	NULL
,	NULL
K.	NULL
Ozawa	NULL
,	NULL
and	NULL
S.	NULL
Asano	NULL
.	NULL

1996	NULL
.	NULL

Interleukin-6	NULL
and	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
synergistically	NULL
increase	NULL
peripheral	NULL
blood	NULL
progenitor	NULL
cells	NULL
in	NULL
myelosuppressive	NULL
mice	NULL
.	NULL

Jpn	NULL
.	NULL

J	NULL
Can	NULL
1183	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39.	NULL
cer	NULL
Res	NULL
.	NULL

87:938-944	NULL
.	NULL

Liu	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
Poursine-Laurent	NULL
,	NULL
H.Y	NULL
.	NULL

Wu	NULL
,	NULL
and	NULL
D.C.	NULL
Link	NULL
.	NULL

1997	NULL
.	NULL

Interleukin-6	NULL
and	NULL
the	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
are	NULL
major	NULL
independent	NULL
regulators	NULL
of	NULL
granulopoiesis	NULL
in	NULL
vivo	NULL
but	NULL
are	NULL
not	NULL
required	NULL
for	NULL
lineage	NULL
commitment	NULL
or	NULL
terminal	NULL
differentiation	NULL
.	NULL

Blood	NULL
.	NULL

90:2583-2590	NULL
.	NULL

Sugita	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Totsuka	NULL
,	NULL
M.	NULL
Saito	NULL
,	NULL
K.	NULL
Yamasaki	NULL
,	NULL
T.	NULL
Taga	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1990	NULL
.	NULL

Functional	NULL
murine	NULL
interleukin	NULL
6	NULL
receptor	NULL
with	NULL
the	NULL
intracisternal	NULL
A	NULL
particle	NULL
gene	NULL
product	NULL
at	NULL
its	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

Its	NULL
possible	NULL
role	NULL
in	NULL
plasmacy-tomagenesis	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171:2001-2009	NULL
.	NULL

McClanahan	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Dalrymple	NULL
,	NULL
M.	NULL
Barkett	NULL
,	NULL
and	NULL
F.	NULL
Lee	NULL
.	NULL

1993	NULL
.	NULL

Hematopoietic	NULL
growth	NULL
factor	NULL
receptor	NULL
genes	NULL
as	NULL
markers	NULL
of	NULL
lineage	NULL
commitment	NULL
during	NULL
in	NULL
vitro	NULL
development	NULL
of	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

$	NULL
1:2903-2915	NULL
.	NULL

Testa	NULL
,	NULL
U.	NULL
,	NULL
C.	NULL
Fossati	NULL
,	NULL
P.	NULL
Samoggia	NULL
,	NULL
R.	NULL
Masciulli	NULL
,	NULL
G.	NULL
Mariani	NULL
,	NULL
H.J	NULL
.	NULL

Hassan	NULL
,	NULL
N.M.	NULL
Sposi	NULL
,	NULL
R.	NULL
Guerriero	NULL
,	NULL
V.	NULL
Rosato	NULL
,	NULL
M.	NULL
Gab-bianelli	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Expression	NULL
of	NULL
growth	NULL
factor	NULL
receptors	NULL
in	NULL
unilineage	NULL
differentiation	NULL
culture	NULL
of	NULL
purified	NULL
hematopoietic	NULL
progenitors	NULL
.	NULL

Blood	NULL
.	NULL

88:3391-3406	NULL
.	NULL

Yamasaki	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Taga	NULL
,	NULL
Y.	NULL
Hirata	NULL
,	NULL
H.	NULL
Yawata	NULL
,	NULL
Y.	NULL
Kawanishi	NULL
,	NULL
B	NULL
.	NULL

Seed	NULL
,	NULL
T.	NULL
Taniguchi	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1988	NULL
.	NULL

Cloning	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
interleukin-6	NULL
(	NULL
BSF-2/	NULL
IFN	NULL
beta	NULL
2	NULL
)	NULL
receptor	NULL
.	NULL

Sdene	NULL
.	NULL

241:825-828	NULL
.	NULL

Taga	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
Y.	NULL
Hirata	NULL
,	NULL
K.	NULL
Yamasaki	NULL
,	NULL
K.	NULL
Yasukawa	NULL
,	NULL
T.	NULL
Matsuda	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1989	NULL
.	NULL

Interleukin-6	NULL
triggers	NULL
the	NULL
association	NULL
of	NULL
its	NULL
receptor	NULL
with	NULL
a	NULL
possible	NULL
signal	NULL
transducer	NULL
,	NULL
gp130	NULL
.	NULL

Coll	NULL
58:573-581	NULL
.	NULL

Hibi	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Murakami	NULL
,	NULL
M.	NULL
Saito	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
T.	NULL
Taga	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1990	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
expression	NULL
of	NULL
an	NULL
IL-6	NULL
signal	NULL
transducer	NULL
,	NULL
gp130	NULL
.	NULL

Cell	NULL
63:1149-1157	NULL
.	NULL

Chen	NULL
,	NULL
H.M.	NULL
,	NULL
P.	NULL
Zhang	NULL
,	NULL
M.T	NULL
.	NULL

Voso	NULL
,	NULL
S.	NULL
Hohaus	NULL
,	NULL
D.A	NULL
.	NULL

Gonzalez	NULL
,	NULL
C.K	NULL
.	NULL

Glass	NULL
,	NULL
D.-E.	NULL
Zhang	NULL
,	NULL
and	NULL
D.G	NULL
.	NULL

Tenen	NULL
.	NULL

1995	NULL
.	NULL

Neutrophils	NULL
and	NULL
monocytes	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
PU.1	NULL
(	NULL
Spi-1	NULL
)	NULL
but	NULL
not	NULL
Spi-B	NULL
.	NULL

Blood	NULL
.	NULL

85:2918-2928	NULL
.	NULL

Jia	NULL
,	NULL
G.Q	NULL
.	NULL

,	NULL
and	NULL
J.C.	NULL
Gutierrez-R	NULL
amos	NULL
.	NULL

1995	NULL
.	NULL

Analysis	NULL
of	NULL
interleukin	NULL
receptor	NULL
gene	NULL
expression	NULL
in	NULL
mouse	NULL
fetal	NULL
liver	NULL
by	NULL
quantitative	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25:2096-2100	NULL
.	NULL

Challita	NULL
,	NULL
P.M.	NULL
,	NULL
D.	NULL
Skelton	NULL
,	NULL
A.	NULL
el-Khoueiry	NULL
,	NULL
X.J	NULL
.	NULL

Yu	NULL
,	NULL
K.	NULL
Weinberg	NULL
,	NULL
and	NULL
D.B	NULL
.	NULL

Kohn	NULL
.	NULL

1995	NULL
.	NULL

Multiple	NULL
modifications	NULL
in	NULL
cis	NULL
elements	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
retroviral	NULL
vectors	NULL
lead	NULL
to	NULL
increased	NULL
expression	NULL
and	NULL
decreased	NULL
DNA	NULL
methylation	NULL
in	NULL
embryonic	NULL
carcinoma	NULL
cells	NULL
.	NULL

J	NULL
Vil	NULL
69:748-755	NULL
.	NULL

Markowitz	NULL
,	NULL
D.	NULL
,	NULL
S.	NULL
Goff	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Bank	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
safe	NULL
packaging	NULL
line	NULL
for	NULL
gene	NULL
transfer	NULL
:	NULL
separating	NULL
viral	NULL
genes	NULL
on	NULL
two	NULL
different	NULL
plasmids	NULL
.	NULL

J	NULL
Virol	NULL
.	NULL

62:1120-1124	NULL
.	NULL

Nicola	NULL
,	NULL
N.A	NULL
.	NULL

,	NULL
and	NULL
D.	NULL
Metcalf	NULL
.	NULL

1985	NULL
.	NULL

Binding	NULL
of	NULL
'	NULL
``	NULL
I-labeled	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
to	NULL
normal	NULL
murine	NULL
hemopoietic	NULL
cells	NULL
.	NULL

J	NULL
Céll	NULL
.	NULL

Physiol	NULL
.	NULL

124:313-321	NULL
.	NULL

Lieschke	NULL
,	NULL
G.J	NULL
.	NULL

,	NULL
D.	NULL
Grail	NULL
,	NULL
G.	NULL
Hodgson	NULL
,	NULL
D.	NULL
Metcalf	NULL
,	NULL
E.	NULL
Stanley	NULL
,	NULL
C.	NULL
Cheers	NULL
,	NULL
K.J	NULL
.	NULL

Fowler	NULL
,	NULL
S.	NULL
Basu	NULL
,	NULL
Y.F	NULL
.	NULL

Zhan	NULL
,	NULL
and	NULL
A.R	NULL
.	NULL

Dunn	NULL
.	NULL

1994	NULL
.	NULL

Mice	NULL
lacking	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
have	NULL
chronic	NULL
neutropenia	NULL
,	NULL
granulocyte	NULL
and	NULL
macrophage	NULL
progenitor	NULL
cell	NULL
deficiency	NULL
,	NULL
and	NULL
impaired	NULL
neutrophil	NULL
mobilization	NULL
.	NULL

Blood	NULL
.	NULL

$	NULL
4:1737-1746	NULL
.	NULL

Grignani	NULL
,	NULL
F.	NULL
,	NULL
M.	NULL
Fagioli	NULL
,	NULL
M.	NULL
Alcalay	NULL
,	NULL
L.	NULL
Longo	NULL
,	NULL
P.P	NULL
.	NULL

Pandolfi	NULL
,	NULL
E.	NULL
Donti	NULL
,	NULL
A.	NULL
Biondi	NULL
,	NULL
F.	NULL
LoCoco	NULL
,	NULL
and	NULL
P.G	NULL
.	NULL

Pelicci	NULL
.	NULL

1994	NULL
.	NULL

Acute	NULL
promyelocytic	NULL
leukemia	NULL
:	NULL
from	NULL
genetics	NULL
to	NULL
treatment	NULL
.	NULL

Blood	NULL
.	NULL

$	NULL
3:10-25	NULL
.	NULL

Arai	NULL
,	NULL
K.L	NULL
.	NULL

,	NULL
F.	NULL
Lee	NULL
,	NULL
A.	NULL
Miyajima	NULL
,	NULL
S.	NULL
Miyatake	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
and	NULL
T.	NULL
Yokota	NULL
.	NULL

1990	NULL
.	NULL

Cytokines	NULL
:	NULL
coordinators	NULL
of	NULL
immune	NULL
and	NULL
inflammatory	NULL
responses	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

59:783-836	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

Keller	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Kennedy	NULL
,	NULL
T.	NULL
Papayannopoulou	NULL
,	NULL
and	NULL
M.V	NULL
.	NULL

Wiles	NULL
.	NULL

1993	NULL
.	NULL

Hematopoietic	NULL
commitment	NULL
during	NULL
embryonic	NULL
stem	NULL
cell	NULL
differentiation	NULL
in	NULL
culture	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
13:473-486	NULL
.	NULL

Schmitt	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
E.	NULL
Bruyns	NULL
,	NULL
and	NULL
H.R	NULL
.	NULL

Snodgrass	NULL
.	NULL

1991	NULL
.	NULL

Hematopoietic	NULL
development	NULL
of	NULL
embryonic	NULL
stem	NULL
cells	NULL
in	NULL
vitro	NULL
:	NULL
cytokine	NULL
and	NULL
receptor	NULL
gene	NULL
expression	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:728-740	NULL
.	NULL

Wu	NULL
,	NULL
H.	NULL
,	NULL
X.	NULL
Liu	NULL
,	NULL
R	NULL
.	NULL

Jaenisch	NULL
,	NULL
and	NULL
H.F.	NULL
Lodish	NULL
.	NULL

1995	NULL
.	NULL

Generation	NULL
of	NULL
committed	NULL
erythroid	NULL
BFU-E	NULL
and	NULL
CFU-E	NULL
progenitors	NULL
does	NULL
not	NULL
require	NULL
erythropoietin	NULL
or	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
.	NULL

Cell	NULL
.	NULL

83:59-67	NULL
.	NULL

Medlock	NULL
,	NULL
E.S	NULL
.	NULL

,	NULL
D.L	NULL
.	NULL

Kaplan	NULL
,	NULL
M.	NULL
Cecchini	NULL
,	NULL
TR	NULL
.	NULL

Ulich	NULL
,	NULL
J.	NULL
del	NULL
Castillo	NULL
,	NULL
and	NULL
J.	NULL
Andresen	NULL
.	NULL

1993	NULL
.	NULL

Granulocyte	NULL
colony-stimulating	NULL
factor	NULL
crosses	NULL
the	NULL
placenta	NULL
and	NULL
stimulates	NULL
fetal	NULL
rat	NULL
granulopoiesis	NULL
.	NULL

Blood	NULL
.	NULL

81:916-922	NULL
.	NULL

Nishinakamura	NULL
,	NULL
R.	NULL
,	NULL
N.	NULL
Nakayama	NULL
,	NULL
Y.	NULL
Hirabayashi	NULL
,	NULL
T.	NULL
Inoue	NULL
,	NULL
D.	NULL
Aud	NULL
,	NULL
T.	NULL
McNeil	NULL
,	NULL
S.	NULL
Azuma	NULL
,	NULL
S.	NULL
Yoshida	NULL
,	NULL
Y.	NULL
Toyoda	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
.	NULL

Mice	NULL
deficient	NULL
for	NULL
the	NULL
IL-3/GM-CSF/	NULL
IL-5	NULL
beta	NULL
c	NULL
receptor	NULL
exhibit	NULL
lung	NULL
pathology	NULL
and	NULL
impaired	NULL
immune	NULL
response	NULL
,	NULL
while	NULL
beta	NULL
IL3	NULL
receptor-deficient	NULL
mice	NULL
are	NULL
normal	NULL
.	NULL

Immunity	NULL
.	NULL

2:211-222	NULL
.	NULL

Kanakura	NULL
,	NULL
Y.	NULL
,	NULL
B.	NULL
Druker	NULL
,	NULL
S.A.	NULL
Cannistra	NULL
,	NULL
Y.	NULL
Furukawa	NULL
,	NULL
Y.	NULL
Torimoto	NULL
,	NULL
and	NULL
J.D	NULL
.	NULL

Griffin	NULL
.	NULL

1990	NULL
.	NULL

Signal	NULL
transduction	NULL
of	NULL
the	NULL
human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
interleukin-3	NULL
receptors	NULL
involves	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
common	NULL
set	NULL
of	NULL
cytoplasmic	NULL
proteins	NULL
.	NULL

Blood	NULL
.	NULL

76:706-715	NULL
.	NULL

Lopez	NULL
,	NULL
A.F	NULL
.	NULL

,	NULL
M.A	NULL
.	NULL

Vadas	NULL
,	NULL
J.M	NULL
.	NULL

Woodcock	NULL
,	NULL
S.E	NULL
.	NULL

Milton	NULL
,	NULL
A.	NULL
Lewis	NULL
,	NULL
M.J.	NULL
Elliott	NULL
,	NULL
D.	NULL
Gillis	NULL
,	NULL
R	NULL
.	NULL

Ireland	NULL
,	NULL
E.	NULL
Olwell	NULL
,	NULL
and	NULL
LS	NULL
.	NULL

1184	NULL
47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

Park	NULL
.	NULL

1991	NULL
.	NULL

Interleukin-5	NULL
,	NULL
interleukin-3	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
crosscompete	NULL
for	NULL
binding	NULL
to	NULL
cell	NULL
surface	NULL
receptors	NULL
on	NULL
human	NULL
eosinophils	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:24741-24747	NULL
.	NULL

Yoshida	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Taga	NULL
,	NULL
M.	NULL
Saito	NULL
,	NULL
S.	NULL
Suematsu	NULL
,	NULL
A.	NULL
Kuman-ogoh	NULL
,	NULL
T.	NULL
Tanaka	NULL
,	NULL
H.	NULL
Fujiwara	NULL
,	NULL
M.	NULL
Hirata	NULL
,	NULL
T.	NULL
Yamagami	NULL
,	NULL
T.	NULL
Nakahata	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
gp130	NULL
,	NULL
a	NULL
common	NULL
signal	NULL
transducer	NULL
for	NULL
the	NULL
interleukin	NULL
6	NULL
family	NULL
of	NULL
cytokines	NULL
,	NULL
leads	NULL
to	NULL
myocardial	NULL
and	NULL
hematological	NULL
disorders	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

93:407-411	NULL
.	NULL

Kopf	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Baumann	NULL
,	NULL
G.	NULL
Freer	NULL
,	NULL
M.	NULL
Freudenberg	NULL
,	NULL
M.	NULL
Lam-ers	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
R.	NULL
Zinkernagel	NULL
,	NULL
H.	NULL
Bluethmann	NULL
,	NULL
and	NULL
G.	NULL
Kohler	NULL
.	NULL

1994	NULL
.	NULL

Impaired	NULL
immune	NULL
and	NULL
acute-phase	NULL
responses	NULL
in	NULL
interleukin-6-deficient	NULL
mice	NULL
.	NULL

Nature	NULL
.	NULL

368:339-342	NULL
.	NULL

Rennick	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Jackson	NULL
,	NULL
G.	NULL
Yang	NULL
,	NULL
J.	NULL
Wideman	NULL
,	NULL
F.	NULL
Lee	NULL
,	NULL
and	NULL
S.	NULL
Hudak	NULL
.	NULL

1989	NULL
.	NULL

Interleukin-6	NULL
interacts	NULL
with	NULL
interleukin-4	NULL
and	NULL
other	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
to	NULL
selectively	NULL
enhance	NULL
the	NULL
growth	NULL
of	NULL
megakaryocytic	NULL
,	NULL
erythroid	NULL
,	NULL
myeloid	NULL
,	NULL
and	NULL
multipotential	NULL
progenitor	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

73:1828-1835	NULL
.	NULL

Walker	NULL
,	NULL
F.	NULL
,	NULL
N.A	NULL
.	NULL

Nicola	NULL
,	NULL
D.	NULL
Metcalf	NULL
,	NULL
and	NULL
A.W	NULL
.	NULL

Burgess	NULL
.	NULL

1985	NULL
.	NULL

Hierarchical	NULL
down-modulation	NULL
of	NULL
hemopoietic	NULL
growth	NULL
factor	NULL
receptors	NULL
.	NULL

Cell	NULL
.	NULL

43:269-276	NULL
.	NULL

Rosenberg	NULL
,	NULL
HF	NULL
.	NULL

,	NULL
S.J	NULL
.	NULL

Ackerman	NULL
,	NULL
and	NULL
D.G	NULL
.	NULL

Tenen	NULL
.	NULL

1990	NULL
.	NULL

An	NULL
alternative	NULL
method	NULL
for	NULL
labeling	NULL
oligonucleotide	NULL
probes	NULL
for	NULL
screening	NULL
cDN	NULL
A	NULL
libraries	NULL
.	NULL

Biotedniques	NULL
.	NULL

8:384	NULL
.	NULL

Arcari	NULL
,	NULL
P.	NULL
,	NULL
R.	NULL
Martinelli	NULL
,	NULL
and	NULL
F.	NULL
Salvatore	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
complete	NULL
sequence	NULL
of	NULL
a	NULL
full-length	NULL
cDNA	NULL
for	NULL
human	NULL
liver	NULL
glycer-aldehyde-3-phosphate	NULL
dehydrogenase	NULL
:	NULL
evidence	NULL
for	NULL
multiple	NULL
mR	NULL
NA	NULL
species	NULL
.	NULL

Nudeic	NULL
A	NULL
dds	NULL
Res	NULL
.	NULL

12:9179-9189	NULL
.	NULL

IL-6	NULL
and	NULL
G-CSF	NULL
Receptors	NULL
in	NULL
Granulopoiesis	NULL

